<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JOP</journal-id>
<journal-id journal-id-type="hwp">spjop</journal-id>
<journal-id journal-id-type="nlm-ta">J Psychopharmacol</journal-id>
<journal-title>Journal of Psychopharmacology</journal-title>
<issn pub-type="ppub">0269-8811</issn>
<issn pub-type="epub">1461-7285</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0269881111425969</article-id>
<article-id pub-id-type="publisher-id">10.1177_0269881111425969</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Evidence for the differential co-localization of neurokinin-1 receptors with 5-HT receptor subtypes in rat forebrain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Hafizi</surname><given-names>Sepehr</given-names></name>
<xref ref-type="aff" rid="aff1-0269881111425969">1</xref>
<xref ref-type="aff" rid="aff2-0269881111425969">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Serres</surname><given-names>Florence</given-names></name>
<xref ref-type="aff" rid="aff1-0269881111425969">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pei</surname><given-names>Qi</given-names></name>
<xref ref-type="aff" rid="aff1-0269881111425969">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Totterdell</surname><given-names>Susan</given-names></name>
<xref ref-type="aff" rid="aff1-0269881111425969">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sharp</surname><given-names>Trevor</given-names></name>
<xref ref-type="aff" rid="aff1-0269881111425969">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0269881111425969"><label>1</label>Department of Pharmacology, University of Oxford, Oxford, UK</aff>
<aff id="aff2-0269881111425969"><label>2</label>Cambridgeshire and Peterborough NHS Foundation Trust, Peterborough, UK</aff>
<author-notes>
<corresp id="corresp1-0269881111425969">Sepehr Hafizi, Cambridgeshire and Peterborough NHS Foundation Trust, 53 Thorpe Road, Peterborough, PE3 6AN, UK Email: <email>sepehr.hafizi@cpft.nhs.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2012</year>
</pub-date>
<volume>26</volume>
<issue>4</issue>
<fpage>505</fpage>
<lpage>515</lpage>
<permissions>
<copyright-statement>Â© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">British Association for Psychopharmacology</copyright-holder>
</permissions>
<abstract>
<p>Studies suggest that like selective 5-hydroxytryptamine (5-HT; serotonin) reuptake inhibitors, antagonists at neurokinin-1 receptors (NK<sub>1</sub>Rs) may have antidepressant and anxiolytic properties. NK<sub>1</sub>Rs are present in 5-HT innervated forebrain regions which may provide a common point of interaction between these two transmitter systems. This study aimed to investigate for cellular co-localization between NK<sub>1</sub>Rs and 5-HT receptor subtypes in mood-related brain regions in the rat forebrain. With experiments using fluorescence immunocytochemistry, double-labelling methods demonstrated a high degree of co-localization between NK<sub>1</sub>Rs and 5-HT<sub>1A</sub> receptors in most regions examined. Co-localization was highest in the medial septum (88% NK<sub>1</sub>R expressing cells were 5-HT<sub>1A</sub> receptor-positive) and hippocampal regions (e.g. dentate gyrus, 65%), followed by the lateral/basolateral amygdala (35%) and medial prefrontal cortex (31%). In contrast, co-localization between NK<sub>1</sub>Rs and 5-HT<sub>2A</sub> receptors was infrequent (&lt; 8%) in most areas examined except for the hippocampus (e.g. CA3, 43%). Overall co-localization between NK<sub>1</sub>Rs and 5-HT<sub>1A</sub> receptors was much greater than that between NK<sub>1</sub>Rs and 5-HT<sub>2A</sub> receptors. Thus, these experiments demonstrate a high degree of co-localization between NK<sub>1</sub>Rs and 5-HT<sub>1A</sub> receptors in cortical and limbic regions of the rat forebrain. These findings suggest a novel site of interaction between NK<sub>1</sub>R antagonists and the 5-HT system.</p>
</abstract>
<kwd-group>
<kwd>5-HT1A receptor</kwd>
<kwd>5-HT2A receptor</kwd>
<kwd>5-hydroxytryptamine</kwd>
<kwd>antidepressant</kwd>
<kwd>limbic system</kwd>
<kwd>NK1 receptor</kwd>
<kwd>Substance P</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0269881111425969" sec-type="intro">
<title>Introduction</title>
<p>The neuropeptide Substance P acts via central neurokinin-1 receptors (NK<sub>1</sub>Rs) to modulate the processing of emotional and stressful stimuli (<xref ref-type="bibr" rid="bibr14-0269881111425969">Commons, 2010</xref>; <xref ref-type="bibr" rid="bibr23-0269881111425969">Ebner et al., 2009</xref>; <xref ref-type="bibr" rid="bibr64-0269881111425969">Mantyh et al., 1984</xref>; <xref ref-type="bibr" rid="bibr76-0269881111425969">Nakaya et al., 1994</xref>). Pre-clinical studies showed that Substance P and NK<sub>1</sub>R agonists induced anxiety, while NK<sub>1</sub>R antagonists exhibited anxiolytic and antidepressant properties (<xref ref-type="bibr" rid="bibr14-0269881111425969">Commons, 2010</xref>; <xref ref-type="bibr" rid="bibr81-0269881111425969">Papp et al., 2000</xref>; <xref ref-type="bibr" rid="bibr89-0269881111425969">Rotzinger et al., 2010</xref>; <xref ref-type="bibr" rid="bibr90-0269881111425969">Rupniak and Kramer, 1999</xref>). In support of these findings, NK<sub>1</sub>R knockout mice displayed marked reductions in anxiety and stress-related behaviours (<xref ref-type="bibr" rid="bibr92-0269881111425969">Santarelli et al., 2001</xref>).</p>
<p>An initial phase II clinical trial in depression showed the NK<sub>1</sub>R antagonist aprepitant (MK-869) to be more effective than placebo and as effective as the selective serotonin reuptake inhibitor, paroxetine (<xref ref-type="bibr" rid="bibr54-0269881111425969">Kramer et al., 1998</xref>). Although this was not borne out in a larger trial (<xref ref-type="bibr" rid="bibr49-0269881111425969">Keller et al., 2006</xref>), the antidepressant and anxiolytic efficacy of the NK<sub>1</sub>R antagonist L-759,274 was confirmed in a further phase II trial (<xref ref-type="bibr" rid="bibr55-0269881111425969">Kramer et al., 2004</xref>). Through this link with mood disorders, a recent study also investigated the role of NK<sub>1</sub>Rs in alcoholism (<xref ref-type="bibr" rid="bibr30-0269881111425969">George et al., 2008</xref>). The study used a randomized placebo controlled experimental design to show that the NK<sub>1</sub>R antagonist LY686017 could suppress cravings for alcohol in recently detoxified alcoholic patients. Analogous effects of LY686017 were also seen with brain functional magnetic resonance imaging on responses to affective stimuli (<xref ref-type="bibr" rid="bibr30-0269881111425969">George et al., 2008</xref>). However, further studies are required to confirm the role of NK<sub>1</sub>Rs in the treatment of alcohol dependence (<xref ref-type="bibr" rid="bibr40-0269881111425969">Heilig et al., 2010</xref>).</p>
<p>A human post-mortem brain study showed decreased NK<sub>1</sub>R numbers in orbitofrontal cortical regions of depressed patients (<xref ref-type="bibr" rid="bibr101-0269881111425969">Stockmeier et al., 2002</xref>). Another study observed a lowered ratio of superficial to deep laminar binding for NK1Rs in the anterior cingulate cortex in depression (<xref ref-type="bibr" rid="bibr8-0269881111425969">Burnet and Harrison, 2000</xref>), while another post-mortem study did not show a difference in NK1R binding in the amygdala in depression (<xref ref-type="bibr" rid="bibr9-0269881111425969">Carletti et al., 2005</xref>).</p>
<p>In addition to the clinical trials noted above, other studies have implicated the neurokinin system in anxiety. For example, in one study Substance P levels were found to be elevated in the cerebrospinal fluid of patients with post-traumatic stress disorder (<xref ref-type="bibr" rid="bibr31-0269881111425969">Geracioti et al., 2006</xref>). A more recent positron emission tomography study showed NK<sub>1</sub>R numbers to be reduced in patients with a history of panic disorder (<xref ref-type="bibr" rid="bibr27-0269881111425969">Fujimura et al., 2009</xref>), and NK<sub>1</sub>R antagonists have been investigated for their role in social phobia (<xref ref-type="bibr" rid="bibr28-0269881111425969">Furmark et al., 2005</xref>) and specific phobias (<xref ref-type="bibr" rid="bibr69-0269881111425969">Michelgard et al., 2007</xref>).</p>
<p>There is a well-established link between depression, anxiety disorders and 5-hydroxytryptamine (5-HT; serotonin), and a number of studies suggest that NK<sub>1</sub>Rs interact with the 5-HT system (<xref ref-type="bibr" rid="bibr6-0269881111425969">Blier et al., 2004</xref>; <xref ref-type="bibr" rid="bibr15-0269881111425969">Commons et al., 2003</xref>; <xref ref-type="bibr" rid="bibr16-0269881111425969">Conley et al., 2002</xref>; <xref ref-type="bibr" rid="bibr56-0269881111425969">Lacoste et al., 2006</xref>; <xref ref-type="bibr" rid="bibr67-0269881111425969">Maubach et al., 2002</xref>). Many of these studies have explored this interaction in mood regulating regions such as the midbrain raphe and locus coeruleus. For example, Substance P infused in vivo into the dorsal raphe nuclei was associated with decreased 5-HT cell firing (<xref ref-type="bibr" rid="bibr103-0269881111425969">Valentino et al., 2003</xref>), while NK<sub>1</sub>R deletion (<xref ref-type="bibr" rid="bibr16-0269881111425969">Conley et al., 2002</xref>; <xref ref-type="bibr" rid="bibr92-0269881111425969">Santarelli et al., 2001</xref>) and NK<sub>1</sub>R antagonists increased neuronal firing in dorsal raphe nuclei (<xref ref-type="bibr" rid="bibr37-0269881111425969">Haddjeri and Blier, 2001</xref>). Interestingly, NK<sub>1</sub>R-/- mice also showed 5-HT<sub>1A</sub> somatodendritic autoreceptor desensitization (<xref ref-type="bibr" rid="bibr26-0269881111425969">Froger et al., 2001</xref>), similar to chronic treatment with selective serotonin reuptake inhibitors (<xref ref-type="bibr" rid="bibr88-0269881111425969">Riad et al., 2004</xref>) and the NK<sub>1</sub>R antagonist GR-205,171 (<xref ref-type="bibr" rid="bibr35-0269881111425969">Guiard et al., 2005</xref>). Furthermore, recent studies have also localized NK<sub>1</sub>Rs to a subpopulation of 5-HT neurons in the dorsal raphe (<xref ref-type="bibr" rid="bibr56-0269881111425969">Lacoste et al., 2006</xref>, <xref ref-type="bibr" rid="bibr57-0269881111425969">2009</xref>). In addition, the effects of modulation of NK<sub>1</sub>Rs on 5-HT levels in the cortex have been studied. For example, intracerebral in vivo microdialysis has shown that increases in cortical 5-HT overflow caused by paroxetine were higher in freely moving NK<sub>1</sub>R-/- mutants than in wild-type mice (<xref ref-type="bibr" rid="bibr41-0269881111425969">Herpfer et al., 2005</xref>), and that administration of the NK<sub>1</sub>R antagonist GR-205,171 to wild-type mice potentiated paroxetine-induced increases in cortical 5-HT dialysate (<xref ref-type="bibr" rid="bibr35-0269881111425969">Guiard et al., 2005</xref>).</p>
<p>In other studies NK<sub>1</sub>R antagonists increased the firing rate of noradrenergic neurons in the locus coeruleus (<xref ref-type="bibr" rid="bibr67-0269881111425969">Maubach et al., 2002</xref>). In addition, a reciprocal interaction has been shown between the dorsal raphe nucleus and the locus coeruleus (<xref ref-type="bibr" rid="bibr34-0269881111425969">Gobbi et al., 2007</xref>). Both the genetic deletion and pharmacological blockade of NK<sub>1</sub>Rs increased 5-HT neuronal firing (<xref ref-type="bibr" rid="bibr34-0269881111425969">Gobbi et al., 2007</xref>), but this increase was mediated by noradrenergic neurons: in fact a selective lesion of the noradrenergic neurons prevented the enhancement of 5-HT firing activity by NK<sub>1</sub>RAs (<xref ref-type="bibr" rid="bibr34-0269881111425969">Gobbi et al., 2007</xref>).</p>
<p>A recent study explored the effects of NK<sub>1</sub>Rs in the lateral septum and the interaction with 5-HT (<xref ref-type="bibr" rid="bibr22-0269881111425969">Ebner et al., 2008</xref>). The investigators found that acute administration of NK<sub>1</sub>R antagonist L-822429 into the lateral septum reduced stress coping strategies in the forced swim test, and that this effect may be modulated by 5-HT<sub>1A</sub> receptors. Immunocytochemical experiments in the lateral septum showed NK<sub>1</sub>Rs localized to calbindin-positive neurons, suggesting that NK<sub>1</sub>R antagonists may influence 5-HT transmission indirectly via gamma-amino butyric acid (GABA) (<xref ref-type="bibr" rid="bibr22-0269881111425969">Ebner et al., 2008</xref>).</p>
<p>Despite the above, little is known about the anatomical interaction of the NK<sub>1</sub>R and 5-HT systems at the level of the forebrain. Indeed, the levels of NK<sub>1</sub>Rs are high in some brain regions that receive 5-HT innervations from the midbrain raphe nuclei including the prefrontal cortex, septum, hippocampus and amygdala (<xref ref-type="bibr" rid="bibr5-0269881111425969">Barnes and Sharp, 1999</xref>; <xref ref-type="bibr" rid="bibr76-0269881111425969">Nakaya et al., 1994</xref>). In these regions, 5-HT acts via a diversity of postsynaptic 5-HT receptor subtypes, including 5-HT<sub>1A</sub> receptors (5-HT<sub>1A</sub>Rs) and 5-HT<sub>2A</sub> receptors (5-HT<sub>2A</sub>Rs), which are known to be important in the aetiology of depression and the mechanism of action of antidepressants (<xref ref-type="bibr" rid="bibr93-0269881111425969">Santarelli et al., 2003</xref>; <xref ref-type="bibr" rid="bibr94-0269881111425969">Sargent et al., 2000</xref>; <xref ref-type="bibr" rid="bibr100-0269881111425969">Stockmeier, 2003</xref>). It is notable that regions which are abundant in 5-HT<sub>1A</sub>Rs, such as the septum, hippocampus and frontal and entorhinal cortices, are also abundant in NK<sub>1</sub>Rs (<xref ref-type="bibr" rid="bibr4-0269881111425969">Aznar et al., 2003</xref>; <xref ref-type="bibr" rid="bibr12-0269881111425969">Clement et al., 1996</xref>; <xref ref-type="bibr" rid="bibr52-0269881111425969">Kia et al., 1996c</xref>; <xref ref-type="bibr" rid="bibr87-0269881111425969">Pompeiano et al., 1992</xref>; <xref ref-type="bibr" rid="bibr107-0269881111425969">Wright et al., 1995</xref>). Similarly, 5-HT<sub>2A</sub>Rs are distributed in the olfactory region, striatum, cortex, hippocampus and amygdala, which also contain NK<sub>1</sub>Rs (<xref ref-type="bibr" rid="bibr17-0269881111425969">Cornea-Hebert et al., 1999</xref>; <xref ref-type="bibr" rid="bibr109-0269881111425969">Xu and Pandey, 2000</xref>). Thus, NK<sub>1</sub>Rs and major 5-HT receptor subtypes are found in similar regions in the forebrain, which may represent a potential site of interaction between NK<sub>1</sub>R antagonists, the 5-HT system and the modulation of mood.</p>
<p>The present study used double-labelling immunofluorescent microscopy to investigate the degree of cellular co-localization between NK<sub>1</sub>Rs and 5-HT<sub>1A</sub>Rs and 5-HT<sub>2A</sub>Rs in rat forebrain regions including the prefrontal cortex, septum, hippocampus and amygdala.</p>
</sec>
<sec id="section2-0269881111425969" sec-type="materials|methods">
<title>Methods and materials</title>
<sec id="section3-0269881111425969">
<title>Animals</title>
<p>Male Sprague-Dawley rats (Harlan-Olac, Bicester, UK) were housed in cages in a temperature-controlled environment with a 12 h light/dark cycle (lights on at 07:00) and allowed free access to food and water. Animal experiments were carried out according to Home Office guidelines and UK Animals (Scientific Procedures) Act 1986, and were designed to minimize animal suffering and number of animals used.</p>
</sec>
<sec id="section4-0269881111425969">
<title>Tissue processing and immunohistochemistry</title>
<sec id="section5-0269881111425969">
<title>5-HT receptor and NK<sub>1</sub> receptor co-localization</title>
<p>One group of six adult rats (250â370 g) were examined for NK<sub>1</sub>R and 5-HT<sub>1A</sub>R co-localization, while in a separate experiment a second group of six adult rats (230â250 g) were examined for NK<sub>1</sub>R and 5-HT<sub>2A</sub>R co-localization. Rats were deeply anaesthetized with intraperitoneal sodium pentobarbital (Merial Animal Health Ltd, Harlow, UK; 200 mg/kg) and transcardially perfused with 200 ml buffer (0.9% saline for 5-HT<sub>1A</sub>R; phosphate buffer for 5-HT<sub>2A</sub>R) followed by about 300 ml of ice-cold fixative composed of 4% (w/v) paraformaldehyde (Agar Scientific, Stansted, UK) and 0.4% (v/v) saturated aqueous picric acid in 0.1 M phosphate buffer at pH 6.9 for 20 min.</p>
<p>For the NK<sub>1</sub>R and 5-HT<sub>1A</sub>R co-localization experiment, the brains were removed and post-fixed in the above solution overnight at 4Â°C. Brains were then cut into smaller blocks before sectioning. Coronal sections (40 Âµm) were prepared using a vibrating microtome (Leica, Milton Keynes, UK) at rostrocaudal bregma levels of 2.70 mm, 0.70 mm and â3.30 mm according to the Paxinos and Watson atlas (see <xref ref-type="fig" rid="fig1-0269881111425969">Figure 1</xref>) (<xref ref-type="bibr" rid="bibr83-0269881111425969">Paxinos and Watson, 1998</xref>). The sections were collected as free-floating sections in ice-cold phosphate-buffered saline (PBS, pH 7.4, components 0.14 M sodium chloride, 0.003 M potassium chloride, 0.01 M phosphate buffer) and after washes in PBS, stored at 4Â°C in PBS with 0.1% (w/v) sodium azide preservative. Following washes in PBS, sections were incubated for 90 min at room temperature in blocking buffer composed of 0.3% (v/v) Triton X-100, 10% (v/v) normal goat serum and 1% (w/v) bovine serum albumin in PBS, and then incubated overnight at 4Â°C with rabbit NK<sub>1</sub>R (Chemicon, CA, USA; 1:2000; AB5060) and guinea pig 5-HT<sub>1A</sub>R primary antibodies (Chemicon; 1:1000; AB5406). The sections were then washed in PBS followed by incubation in Alexa Fluor 488 goat anti-rabbit (Molecular Probes, Netherlands; 1:1000) and Alexa Fluor 568 goat anti-guinea pig secondary antibodies (Molecular Probes; 1:500) for 4 h at room temperature, while protected from light. All anti-sera were diluted in PBS, 0.3% Triton X-100, 1% normal goat serum and 1% bovine serum albumin. After further washes, sections were mounted from a buffer bath onto gelatine-coated glass slides, allowed to air-dry while protected from light before being cover-slipped with Vectashield liquid mounting medium (Vector Laboratories, Peterborough, UK). Controls included omitting the primary antibody as well as comparisons for cross-reactivity between a primary antibody and the unrelated secondary antibody.</p>
<fig id="fig1-0269881111425969" position="float">
<label>Figure 1.</label>
<caption><p>Schematic diagram of coronal rat forebrain sections with regions examined for co-localization. Brain regions examined were: the infralimbic (IL) and the prelimbic (PL) regions combined to represent the prefrontal cortex; FCx represents the frontal cortex (bregma 2.70 mm); the septum (medial septum and diagonal band of Broca complex (MS) and lateral septum (LS) (bregma 0.70 mm); the hippocampal sub-regions (dentate gyrus [DG], CA1 and CA3) and amygdala (lateral and basolateral aspects [LA/BLA]) (bregma â3.30 mm). Percentage co-localization of NK<sub>1</sub> and 5-HT receptors illustrated as quintiles: (A) NK<sub>1</sub>R and 5-HT<sub>1A</sub>R; (B) NK<sub>1</sub>R and 5-HT<sub>2A</sub>R. 5-HT1AR: 5-HT<sub>1A</sub> receptors, 5-HT2AR: 5-HT<sub>2A</sub> receptors, NK1R: NK<sub>1</sub> receptors. (Adapted from <xref ref-type="bibr" rid="bibr83-0269881111425969">Paxinos G and Watson C (1998)</xref> <italic>The Rat Brain in Streretaxic Coordinates</italic> with permission from Elsevier).</p></caption>
<graphic xlink:href="10.1177_0269881111425969-fig1.tif"/>
</fig>
<p>For the NK<sub>1</sub>R and 5-HT<sub>2A</sub>R co-localization experiment, the process was as described above with minor differences. Brains were post-fixed at 4Â°C for 4 h and then transferred for about 36 h to 30% (w/v) sucrose in PBS for cryoprotection at 4Â°C. Coronal sections (30 Âµm) were then collected via a freezing sliding microtome (Leica Microsystems, Germany). Incubation with monoclonal mouse 5-HT<sub>2A</sub>R primary antibody (Pharmingen; 1:1000; #556326) was for three nights at 4Â°C, with rabbit NK<sub>1</sub>R primary antibody (Chemicon; 1:2000) added on the final night. The secondary antibody used for 5-HT<sub>2A</sub>R was Alexa Fluor 568 goat anti-mouse antibody (Molecular Probes; 1:1000).</p>
</sec>
<sec id="section6-0269881111425969">
<title>Fluorescence microscopy and histological analysis</title>
<p>Tissue sections were initially examined using a Leitz Diaplan microscope (Leica, Germany) fitted with an incident 50 Watt mercury arc lamp and equipped with epifluorescence optics and dichroic filters and viewed via a Leitz PL-Fluotar objective (Ã 40 numerical aperture = 0.7). Filters used were as follows: green fluorophore 420â490 excitation band-pass and 520 nm emission long-pass; red fluorophore 530â560 nm excitation band-pass and 580 nm emission long-pass.</p>
<p>Cell counts were collected at Ã 40 objective throughout. Cell counting was carried out on sections from the prefrontal cortex (prelimbic plus infralimbic regions), frontal cortex (regions M1 and M2), lateral septum (bilaterally) and medial septum including the diagonal band of Broca, amygdala (lateral and basolateral combined) and hippocampus (dentate gyrus, CA1, CA3). Cell counts for co-localized NK<sub>1</sub>R immunoreactivity (-ir) and 5-HT receptor-ir were made bilaterally on three sections, which were collected alternately to avoid counting the same cells twice. All NK<sub>1</sub>R-ir positive cells were counted in defined anatomical areas according to the Paxinos and Watson atlas (see <xref ref-type="fig" rid="fig1-0269881111425969">Figure 1</xref>) (<xref ref-type="bibr" rid="bibr83-0269881111425969">Paxinos and Watson, 1998</xref>). Percentage co-localization is presented as mean of six brains +/â standard error of the mean.</p>
<p>Digital images of sections with NK<sub>1</sub>R-ir and 5-HT<sub>1A</sub>R-ir double-labelling were captured using a cooled colour CCD camera (model C4742-95; Hamamatsu, Welwyn Garden City, UK) on a Leica (Wetzlar, Germany) DMRB microscope with epifluorescence illumination equipped with the following filter blocks: A4 (excitation filter band-pass, 360/40 nm; reflection short-pass filter, 400 nm; suppression filter band-pass, 470/40 nm), L5 (excitation filter band-pass, 480/40 nm; reflection short-pass filter, 505 nm; suppression filter band-pass, 527/30 nm), Y3 (excitation filter band-pass, 545/30 nm; reflection short-pass filter, 565 nm; suppression filter band-pass, 610/75 nm), and Y5 (excitation filter band-pass, 620/60 nm; reflection short-pass filter, 660 nm; suppression filter B-P, 700/75 nm). Coloured digital images of sections with NK<sub>1</sub>R-ir and 5-HT<sub>2A</sub>R-ir double-labelling were obtained using a Xillix Micro Imager camera (Xillix Technologies Corp., Canada) on the Leitz Diaplan microscope described above.</p>
<p>Images were analysed and displayed using Openlab software (version 3.1.4; Improvision, Coventry, UK). Brightness and contrast were adjusted for the entire frame, and no part of a frame was modified in any way. Digital images were manipulated with regards to size, cropping, colour balance, brightness using Photoshop 5.0 software (Adobe systems, San Jose, CA, USA) on a Power Macintosh computer and later labelled using Powerpoint (Microsoft).</p>
</sec>
</sec>
</sec>
<sec id="section7-0269881111425969" sec-type="results">
<title>Results</title>
<sec id="section8-0269881111425969">
<title>Distribution of NK<sub>1</sub> receptor immunoreactivity</title>
<p>NK<sub>1</sub>R-ir was detected throughout the forebrain, and showed a regional distribution similar to that shown previously (<xref ref-type="bibr" rid="bibr76-0269881111425969">Nakaya et al., 1994</xref>). As with previous studies, NK<sub>1</sub>R-ir was most predominantly observed on the cell membranes of neuronal somata and fibres (<xref ref-type="bibr" rid="bibr11-0269881111425969">Chen et al., 2001</xref>; <xref ref-type="bibr" rid="bibr38-0269881111425969">Hahn and Bannon, 1999</xref>). Strong expression for NK<sub>1</sub>R-ir was present on cell membranes in all parts of the medial septum-diagonal band of Broca complex (<xref ref-type="fig" rid="fig2-0269881111425969">Figures 2A</xref>, <xref ref-type="fig" rid="fig2-0269881111425969">2C</xref>, <xref ref-type="fig" rid="fig2-0269881111425969">2E</xref>, <xref ref-type="fig" rid="fig2-0269881111425969">2G</xref>). NK<sub>1</sub>R-ir was also observed on cells and fibres in hippocampal sub-regions. In the dentate gyrus in particular, strong expression of NK<sub>1</sub>R-ir was seen on a network of fibres (<xref ref-type="fig" rid="fig3-0269881111425969">Figure 3A</xref>). NK<sub>1</sub>R-ir was less dense in the basolateral amygdala and the medial prefrontal cortex (<xref ref-type="fig" rid="fig3-0269881111425969">Figures 3E</xref>, <xref ref-type="fig" rid="fig3-0269881111425969">3G</xref>).</p>
<fig id="fig2-0269881111425969" position="float">
<label>Figure 2.</label>
<caption><p>Photomicrographs of NK<sub>1</sub> and 5-HT<sub>1A</sub> receptor immunoreactivities in medial septum and vertical diagonal band of Broca. Higher magnification photographs of the square in A + B are shown in C, D and C + D. 5-HT<sub>1A</sub>R-ir and NK<sub>1</sub>R-ir cell bodies are observed in the medial septum (MS) (C, D and C + D). Similarly, higher magnification photographs of the square in E + F are shown in G, H and G + H. 5-HT<sub>1A</sub>R-ir and NK<sub>1</sub>R-ir cell bodies are observed in the vertical diagonal band of Broca (VDBB) (G, H and G + H). Cells co-localized for NK1R-ir and 5-HT1AR-ir are observed in the MS (arrows in C, D, C + D), and the VDBB (arrows in G, H and G + H). Scale bars: A + B, 120 Âµm; C + D, 30 Âµm; E + F, 120 Âµm; G + H, 30 Âµm.</p></caption>
<graphic xlink:href="10.1177_0269881111425969-fig2.tif"/>
</fig>
<fig id="fig3-0269881111425969" position="float">
<label>Figure 3.</label>
<caption><p>Photomicrographs of NK<sub>1</sub> and 5-HT<sub>1A</sub> receptor immunoreactivities in dentate gyrus of hippocampus and prelimbic region of the prefrontal cortex. In the dentate gyrus, lower magnification photomicrographs reveal extensive NK<sub>1</sub>R-ir in fibres (A) and extensive 5-HT<sub>1A</sub>R-ir in cell bodies (B) in the dentate gyrus. Higher magnification photographs of the square in A + B are shown in C, D and C + D. The cell arrowed (C, D, C + D) shows co-localization for NK<sub>1</sub>R-ir and 5- HT<sub>1A</sub>R-ir (C + D). In the prefrontal cortex, lower magnification photomicrographs reveal sparse NK1R-ir in cell bodies with extensive NK1R-ir in fibres (E) and weak, but extensive 5-HT<sub>1A</sub>R-ir in cell bodies (F). Higher magnification photographs of the square in E + F are shown in G, H and G + H. A cell co-localizing NK<sub>1</sub>R-ir and 5-HT<sub>1A</sub>R-ir is observed (arrowed in G, H and G + H). Scale bars: A + B, 120 Âµm; C + D, 30 Âµm; E + F, 60 Âµm; G + H, 30 Âµm.</p></caption>
<graphic xlink:href="10.1177_0269881111425969-fig3.tif"/>
</fig>
</sec>
<sec id="section9-0269881111425969">
<title>Distribution of 5-HT<sub>1A</sub> receptor immunoreactivity</title>
<p>5-HT<sub>1A</sub>R-ir was detected throughout the rat forebrain regions studied, and this followed the pattern observed previously (<xref ref-type="bibr" rid="bibr13-0269881111425969">Collin et al., 2002</xref>; <xref ref-type="bibr" rid="bibr50-0269881111425969">Kia et al., 1996a</xref>, <xref ref-type="bibr" rid="bibr51-0269881111425969">1996b</xref>, <xref ref-type="bibr" rid="bibr52-0269881111425969">1996c</xref>; <xref ref-type="bibr" rid="bibr62-0269881111425969">Luttgen et al., 2005</xref>; <xref ref-type="bibr" rid="bibr66-0269881111425969">Martin-Ruiz et al., 2001</xref>; <xref ref-type="bibr" rid="bibr79-0269881111425969">Ou et al., 2003</xref>). As in the other studies, 5-HT<sub>1A</sub>R-ir was predominantly seen in cell soma and only occasionally in dendrites. 5-HT<sub>1A</sub>R-ir was prominent on cells in midline and lateral zones of the medial septum (<xref ref-type="fig" rid="fig2-0269881111425969">Figures 2B</xref>, <xref ref-type="fig" rid="fig2-0269881111425969">2D</xref>) and in the diagonal band of Broca (<xref ref-type="fig" rid="fig2-0269881111425969">Figures 2F</xref>, <xref ref-type="fig" rid="fig2-0269881111425969">2H</xref>). 5-HT<sub>1A</sub>R-ir was also abundant in hippocampal dentate gyrus (<xref ref-type="fig" rid="fig3-0269881111425969">Figure 3B</xref>), but with prominent immunoreactivity in hilar regions and only faint 5-HT<sub>1A</sub>R-ir within the granule cell layer. Abundant 5-HT<sub>1A</sub>R-ir was also observed in hippocampal CA1 and CA3 as well as the basolateral amygdala, prefrontal cortex (<xref ref-type="fig" rid="fig3-0269881111425969">Figures 3F</xref>, <xref ref-type="fig" rid="fig3-0269881111425969">3H</xref>) and frontal cortex.</p>
</sec>
<sec id="section10-0269881111425969">
<title>Distribution of 5-HT<sub>2A</sub> receptor immunoreactivity</title>
<p>5-HT<sub>2A</sub>R-ir was detected throughout the rat forebrain in concordance with previous reports (<xref ref-type="bibr" rid="bibr61-0269881111425969">Luttgen et al., 2004</xref>; <xref ref-type="bibr" rid="bibr108-0269881111425969">Wu et al., 1998</xref>; <xref ref-type="bibr" rid="bibr109-0269881111425969">Xu and Pandey, 2000</xref>) and was distinct from that of 5-HT<sub>1A</sub>R-ir. Here, the cellular distribution of 5-HT<sub>2A</sub>R-ir showed a predominantly somatodendritic neuronal localization as has been previously described (<xref ref-type="bibr" rid="bibr66-0269881111425969">Martin-Ruiz et al., 2001</xref>; <xref ref-type="bibr" rid="bibr71-0269881111425969">Miner et al., 2003</xref>; <xref ref-type="bibr" rid="bibr77-0269881111425969">Nocjar et al., 2002</xref>). Cellular expression of 5-HT<sub>2A</sub>R-ir was observed in the medial septum and diagonal band of Broca, the hippocampus, e.g. CA3 (<xref ref-type="fig" rid="fig4-0269881111425969">Figure 4B</xref>), and basolateral amygdala. Within the prefrontal cortex, 5-HT<sub>2A</sub>R-ir was prominent on both cell bodies and fibres.</p>
<fig id="fig4-0269881111425969" position="float">
<label>Figure 4.</label>
<caption><p>Photomicrographs of NK<sub>1</sub> and 5-HT<sub>2A</sub> receptor immunoreactivities in CA3 region of hippocampus. Higher magnification photomicrographs of the square in A + B are shown in C, D and C + D. Cells co-localizing NK<sub>1</sub>R-ir and 5-HT<sub>2A</sub>R-ir are observed (arrowed in C, D and C + D). Cells with only NK<sub>1</sub>R-ir are also observed (arrowheads in C and C + D). so: Stratum oriens, sp: Stratum pyramidale, sr: Stratum radiatum. Scale bars: A + B, 80 Âµm; C + D, 50 Âµm.</p></caption>
<graphic xlink:href="10.1177_0269881111425969-fig4.tif"/>
</fig>
</sec>
<sec id="section11-0269881111425969">
<title>NK<sub>1</sub> and 5-HT<sub>1A</sub> receptor co-localization</title>
<p>In this study, the brain regions rich in NK<sub>1</sub>R-ir were also rich in 5-HT<sub>1A</sub>R-ir. Cellular co-localization between NK<sub>1</sub>R-ir and 5-HT<sub>1A</sub>R-ir was frequent in most areas examined. The highest percentage of co-localization was present in medial septum-diagonal band of Broca complex (88.0%), dentate gyrus (65.1%) and CA3 regions (62.5%). Moderate co-localization was seen in the basolateral amygdala (34.5%), hippocampal CA1 region (32.4%), frontal cortex (32.0%) and prefrontal cortex (31.1%). Very little co-localization (3.9%) was found in the lateral septum (see <xref ref-type="table" rid="table1-0269881111425969">Table 1</xref> and <xref ref-type="fig" rid="fig1-0269881111425969">Figure 1A</xref>). <xref ref-type="fig" rid="fig2-0269881111425969">Figure 2</xref> depicts 5-HT<sub>1A</sub>R-ir and NK<sub>1</sub>R-ir co-localization on neurons in the medial septum (<xref ref-type="fig" rid="fig2-0269881111425969">Figures 2, C + D</xref>) and vertical diagonal band of Broca (<xref ref-type="fig" rid="fig2-0269881111425969">Figures 2, G + H</xref>), whilst <xref ref-type="fig" rid="fig3-0269881111425969">Figure 3</xref> depicts co-localization in the dentate gyrus (<xref ref-type="fig" rid="fig3-0269881111425969">Figures 3C</xref>, <xref ref-type="fig" rid="fig3-0269881111425969">3D</xref>) and the prefrontal cortex (<xref ref-type="fig" rid="fig3-0269881111425969">Figures 3, G + H</xref>).</p>
<table-wrap id="table1-0269881111425969" position="float">
<label>Table 1.</label>
<caption><p>NK<sub>1</sub> and 5-HT<sub>1A</sub> receptor co-localization in rat forebrain</p></caption>
<graphic alternate-form-of="table1-0269881111425969" xlink:href="10.1177_0269881111425969-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Brain area</th>
<th align="left">Total no. of NK<sub>1</sub>R-ir cells</th>
<th align="left">No. of NK<sub>1</sub>R-ir cells expressing 5-HT<sub>1A</sub>R-ir</th>
<th align="left">Percentage co-localization Mean (SEM)</th>
</tr>
</thead>
<tbody>
<tr>
<td>mPFC<sup><xref ref-type="table-fn" rid="table-fn1-0269881111425969">a</xref></sup></td>
<td>415</td>
<td>135</td>
<td>31.1 (4.8)</td>
</tr>
<tr>
<td>Frontal cortex<sup><xref ref-type="table-fn" rid="table-fn1-0269881111425969">b</xref></sup></td>
<td>1422</td>
<td>455</td>
<td>32.0 (1.7)</td>
</tr>
<tr>
<td>Lateral septum<sup><xref ref-type="table-fn" rid="table-fn1-0269881111425969">c</xref></sup></td>
<td>1813</td>
<td>76</td>
<td>3.9 (1.3)</td>
</tr>
<tr>
<td>Medialseptum<sup><xref ref-type="table-fn" rid="table-fn1-0269881111425969">c</xref></sup></td>
<td>2642</td>
<td>2342</td>
<td>88.0 (0.7)</td>
</tr>
<tr>
<td>Amygdala<sup><xref ref-type="table-fn" rid="table-fn1-0269881111425969">d</xref></sup></td>
<td>384</td>
<td>144</td>
<td>34.5 (2.0)</td>
</tr>
<tr>
<td>Dentate gyrus<sup><xref ref-type="table-fn" rid="table-fn1-0269881111425969">e</xref></sup></td>
<td>511</td>
<td>317</td>
<td>65.1 (2.3)</td>
</tr>
<tr>
<td>CA3</td>
<td>459</td>
<td>297</td>
<td>62.5 (3.0)</td>
</tr>
<tr>
<td>CA1</td>
<td>776</td>
<td>233</td>
<td>32.4 (4.4)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0269881111425969">
<p>The total number of NK<sub>1</sub>R-ir cells counted (total from all animals) and the number of cells also immunoreactive for 5-HT<sub>1A</sub>Rs is tabulated together with the mean (SEM) percentage co-localization in different brain regions; in each brain region cell counts were made from both hemispheres in three slices for each brain (total of six brains). <sup>a</sup>Infralimbic/prelimbic regions only. <sup>b</sup>M1 and M2 regions combined. <sup>c</sup>Both hemispheres counted together as one in the septal areas. <sup>d</sup>Lateral/basolateral amygdala only. <sup>e</sup>CA4 not included as part of the dentate gyrus.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section12-0269881111425969">
<title>NK<sub>1</sub> and 5-HT<sub>2A</sub> receptor co-localization</title>
<p>Co-localization between NK<sub>1</sub>R-ir and 5-HT<sub>2A</sub>R-ir was infrequent (&lt; 8%) in most areas except for hippocampus: dentate gyrus (15.9%), CA1 (24.8%) and CA3 (43.1%) as shown in <xref ref-type="table" rid="table2-0269881111425969">Table 2</xref> and illustrated in <xref ref-type="fig" rid="fig1-0269881111425969">Figure 1B</xref>. An example of 5-HT<sub>2A</sub>R-ir and NK<sub>1</sub>R-ir co-localization is depicted on CA3 neurons in <xref ref-type="fig" rid="fig4-0269881111425969">Figure 4, C + D</xref>.</p>
<table-wrap id="table2-0269881111425969" position="float">
<label>Table 2.</label>
<caption><p>NK<sub>1</sub> and 5-HT<sub>2A</sub> receptor co-localization in rat forebrain</p></caption>
<graphic alternate-form-of="table2-0269881111425969" xlink:href="10.1177_0269881111425969-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Brain area</th>
<th align="left">Total no. of NK<sub>1</sub>R-ir cells</th>
<th align="left">No. of NK<sub>1</sub>R-ir cells expressing 5-HT<sub>2A</sub>R-ir</th>
<th align="left">Percentage co-localization Mean (SEM)</th>
</tr>
</thead>
<tbody>
<tr>
<td>mPFC<sup><xref ref-type="table-fn" rid="table-fn2-0269881111425969">a</xref></sup></td>
<td>414</td>
<td>9</td>
<td>1.7 (1.1)</td>
</tr>
<tr>
<td>Frontal cortex<sup><xref ref-type="table-fn" rid="table-fn2-0269881111425969">b</xref></sup></td>
<td>1429</td>
<td>71</td>
<td>5.1 (1.1)</td>
</tr>
<tr>
<td>Medial septum<sup><xref ref-type="table-fn" rid="table-fn2-0269881111425969">c</xref></sup></td>
<td>1684</td>
<td>113</td>
<td>6.2 (1.2)</td>
</tr>
<tr>
<td>Amygdala<sup><xref ref-type="table-fn" rid="table-fn2-0269881111425969">d</xref></sup></td>
<td>384</td>
<td>36</td>
<td>8.1 (2.7)</td>
</tr>
<tr>
<td>Dentate gyrus<sup><xref ref-type="table-fn" rid="table-fn2-0269881111425969">e</xref></sup></td>
<td>740</td>
<td>124</td>
<td>15.9 (4.6)</td>
</tr>
<tr>
<td>CA3</td>
<td>667</td>
<td>290</td>
<td>43.1 (5.5)</td>
</tr>
<tr>
<td>CA1</td>
<td>882</td>
<td>218</td>
<td>24.8 (3.9)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0269881111425969">
<p>The total number of NK<sub>1</sub>R-ir cells counted (total from all animals) and the number of cells also immunoreactive for 5-HT<sub>2A</sub>Rs is tabulated together with the mean (SEM) percentage co-localization in different brain regions; in each brain region cell counts were made from both hemispheres in three slices for each brain (total of six brains). <sup>a</sup>Infralimbic/prelimbic regions only. <sup>b</sup>M1 and M2 regions combined. <sup>c</sup>Both hemispheres counted together as one in the septal areas. <sup>d</sup>Lateral/basolateral amygdala only. <sup>e</sup>CA4 not included as part of the dentate gyrus.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section13-0269881111425969" sec-type="discussion">
<title>Discussion</title>
<p>Previous studies report the presence of NK<sub>1</sub>Rs in brain regions that receive 5-HT innervations from the midbrain dorsal and median raphe nuclei (<xref ref-type="bibr" rid="bibr5-0269881111425969">Barnes and Sharp, 1999</xref>; <xref ref-type="bibr" rid="bibr76-0269881111425969">Nakaya et al., 1994</xref>). However, it was not known whether NK<sub>1</sub>Rs and 5-HT receptor subtypes co-localize on the same cells. The aim of the current study was to search for evidence of co-localization between NK<sub>1</sub>Rs and 5-HT<sub>1A</sub>Rs, and between NK<sub>1</sub>Rs and 5-HT<sub>2A</sub>Rs in the rat forebrain. This interaction may be important with regards to the antidepressant action of NK<sub>1</sub>R antagonists.</p>
<p>The main findings of the present study were: (1) NK<sub>1</sub>R-ir and 5-HT<sub>1A</sub>R-ir were co-localized to a high degree in many forebrain regions, in particular the medial septum-diagonal band of Broca complex and hippocampus. Co-localization was also present in prefrontal cortex, frontal cortex and lateral and basolateral amygdala, but to a lesser degree. (2) NK<sub>1</sub>R-ir was found to co-localize with 5-HT<sub>2A</sub>Rs in hippocampal sub-regions, but not in other areas investigated. (3) The degree of co-localization between NK<sub>1</sub>R and 5-HT<sub>1A</sub>Rs was much greater than that between NK<sub>1</sub>R and 5-HT<sub>2A</sub>Rs.</p>
<p>The primary antibodies used in the current study have been validated in previous work. The NK<sub>1</sub>R antibody (C-terminal amino acids 385â407; rabbit) was shown to provide specific labelling (<xref ref-type="bibr" rid="bibr15-0269881111425969">Commons et al., 2003</xref>; <xref ref-type="bibr" rid="bibr56-0269881111425969">Lacoste et al., 2006</xref>; <xref ref-type="bibr" rid="bibr60-0269881111425969">Liu et al., 2002</xref>; <xref ref-type="bibr" rid="bibr74-0269881111425969">Myohanen et al., 2008</xref>; <xref ref-type="bibr" rid="bibr76-0269881111425969">Nakaya et al., 1994</xref>; <xref ref-type="bibr" rid="bibr97-0269881111425969">Shigemoto et al., 1993</xref>). In pre-adsorption tests, excess of the fusion protein containing the NK<sub>1</sub>R C-terminal completely blocked immunoreactivity (<xref ref-type="bibr" rid="bibr86-0269881111425969">Piggins et al., 2001</xref>; <xref ref-type="bibr" rid="bibr97-0269881111425969">Shigemoto et al., 1993</xref>), while in another study, polyclonal rabbit anti-NK<sub>1</sub>R serum specifically recognized a broad protein band on Western blots of membranes prepared from cells expressing NK<sub>1</sub>R (<xref ref-type="bibr" rid="bibr104-0269881111425969">Vigna et al., 1994</xref>). In addition, antibody specificity has been tested by the processing of sections from NK<sub>1</sub>R knockout mice (<xref ref-type="bibr" rid="bibr56-0269881111425969">Lacoste et al., 2006</xref>). Furthermore, in our study, control experiments where the primary antibody was excluded did not result in any labelling.</p>
<p>The specificity of the guinea-pig polyclonal 5-HT<sub>1A</sub>R antibody used in our study has been confirmed when preabsorption of 5-HT<sub>1A</sub>R antiserum with immunogen peptide (10<sup>â5</sup> M) corresponding to amino acids 248â262 located within the third intracellular loop of the rat 5-HT<sub>1A</sub>R and the hapten thyroglobulin (0.5 mg/Âµl undiluted antiserum) resulted in marked reduction in immunostaining (<xref ref-type="bibr" rid="bibr13-0269881111425969">Collin et al., 2002</xref>; <xref ref-type="bibr" rid="bibr62-0269881111425969">Luttgen et al., 2005</xref>). The pattern of immunohistochemical staining found in our study was similar to those found in other studies when using the same antibody in the same brain regions (<xref ref-type="bibr" rid="bibr13-0269881111425969">Collin et al., 2002</xref>; <xref ref-type="bibr" rid="bibr62-0269881111425969">Luttgen et al., 2005</xref>; <xref ref-type="bibr" rid="bibr79-0269881111425969">Ou et al., 2003</xref>). As in the other studies, 5-HT<sub>1A</sub>R-ir was predominantly seen in cell soma and occasionally also seen in dendrites.</p>
<p>In our study, 5-HT<sub>1A</sub>R-ir within the dentate gyrus was prominent in hilar regions, but faint in the granule cell layer, and other investigators have found similar results with other polyclonal anti-5-HT<sub>1A</sub>R antibodies (<xref ref-type="bibr" rid="bibr32-0269881111425969">Gerard et al., 1994</xref>; <xref ref-type="bibr" rid="bibr52-0269881111425969">Kia et al., 1996c</xref>; <xref ref-type="bibr" rid="bibr53-0269881111425969">Kim et al., 2007</xref>). However, some other studies using a polyclonal rabbit antibody to the third intracellular loop (amino acids 258â274) (<xref ref-type="bibr" rid="bibr4-0269881111425969">Aznar et al., 2003</xref>) or an antibody raised against the second extracellular loop of the 5-HT<sub>1A</sub>R (amino acids 170-186) (<xref ref-type="bibr" rid="bibr82-0269881111425969">Patel et al., 1996</xref>) did detect 5-HT<sub>1A</sub>R-ir in hippocampal principal cells including the granule cell layer. Similarly, in the lateral septum, the current study found only weak immunostaining for 5-HT<sub>1A</sub>R in neurons, in concordance with one study (<xref ref-type="bibr" rid="bibr62-0269881111425969">Luttgen et al., 2005</xref>), while another study reported strong somatodendritic staining in this region (<xref ref-type="bibr" rid="bibr52-0269881111425969">Kia et al., 1996c</xref>). Different staining patterns from the use of different antibodies may be related to differences in the epitopes recognized by the antibodies. For example, it may be that the antibody recognizing the binding site of the 5-HT<sub>1A</sub>R (amino acids 170-186) will mostly only allow for the visualization of functionally active membrane-bound receptors, and is less likely to allow for the visualization of cytoplasmic receptors that may be in the process of synthesis or degradation (<xref ref-type="bibr" rid="bibr2-0269881111425969">Anthony and Azmitia, 1997</xref>; <xref ref-type="bibr" rid="bibr3-0269881111425969">Azmitia et al., 1992</xref>; <xref ref-type="bibr" rid="bibr18-0269881111425969">Czyrak et al., 2003</xref>). However, no differences in staining patterns have been found in the hippocampus with regards to GABA neurons. Thus any differences in staining patterns on principal cells would not have a bearing on the results of our study. This is because NK<sub>1</sub>Rs are found only in GABA neurons within the rat hippocampus (<xref ref-type="bibr" rid="bibr1-0269881111425969">Acsady et al., 1997</xref>; <xref ref-type="bibr" rid="bibr98-0269881111425969">Sloviter et al., 2001</xref>).</p>
<p>The 5-HT<sub>2A</sub>R antibody used in our study (<xref ref-type="bibr" rid="bibr108-0269881111425969">Wu et al., 1998</xref>) was a monoclonal mouse antiserum generated against a recombinant hybridoma fusion protein between glutathione <italic>S</italic>-transferase (GST) and the first extracellular domain of the human 5-HT<sub>2A</sub>R (amino acids 1â72 of the amino terminus). The hybridomas were screened by Pharmingen using an enzyme-linked immunosorbent assay, immunocytochemistry of frozen rat brain sections, and Western blot analysis: the 5-HT<sub>2A</sub>R antibody recognized the receptor as a 55-kDa band. The specificity of the band was verified by competition with a 5-HT<sub>2A</sub>R fusion protein and lack of competition with an irrelevant fusion protein. The supernatant was also tested against GST protein to rule out reactivity to this part of the immunogen. The antibody was purified from hybridoma culture supernatant by protein G affinity chromatography. In addition, the antibody has specifically been shown to react with human, monkey and rat 5-HT<sub>2A</sub>R (<xref ref-type="bibr" rid="bibr44-0269881111425969">Jakab and Goldman-Rakic, 1998</xref>). Other investigators confirmed the specificity of the antibody by Western blot analysis of rat brain membranes, human brain and transfected NIH 3T3 cell lysates, and immunofluorescence of rat Schwann cells in culture (<xref ref-type="bibr" rid="bibr108-0269881111425969">Wu et al., 1998</xref>; <xref ref-type="bibr" rid="bibr109-0269881111425969">Xu and Pandey, 2000</xref>). The antisera utilized have been characterized and applied in brain tissues, with specificity of labelling demonstrated in many different studies (<xref ref-type="bibr" rid="bibr17-0269881111425969">Cornea-Hebert et al., 1999</xref>; <xref ref-type="bibr" rid="bibr19-0269881111425969">Doherty and Pickel, 2000</xref>; <xref ref-type="bibr" rid="bibr29-0269881111425969">Garlow et al., 1993</xref>; <xref ref-type="bibr" rid="bibr44-0269881111425969">Jakab and Goldman-Rakic, 1998</xref>, <xref ref-type="bibr" rid="bibr45-0269881111425969">2000</xref>; <xref ref-type="bibr" rid="bibr46-0269881111425969">Jansson et al., 1998</xref>, <xref ref-type="bibr" rid="bibr47-0269881111425969">2001</xref>; <xref ref-type="bibr" rid="bibr61-0269881111425969">Luttgen et al., 2004</xref>; <xref ref-type="bibr" rid="bibr63-0269881111425969">McDonald and Mascagni, 2007</xref>; <xref ref-type="bibr" rid="bibr66-0269881111425969">Martin-Ruiz et al., 2001</xref>; <xref ref-type="bibr" rid="bibr71-0269881111425969">Miner et al., 2003</xref>; <xref ref-type="bibr" rid="bibr106-0269881111425969">Willins et al., 1999</xref>; <xref ref-type="bibr" rid="bibr108-0269881111425969">Wu et al., 1998</xref>; <xref ref-type="bibr" rid="bibr109-0269881111425969">Xu and Pandey, 2000</xref>).</p>
<p>The distribution and somatodendritic labelling of 5-HT<sub>2A</sub>R-ir observed here was as demonstrated in many different studies (<xref ref-type="bibr" rid="bibr17-0269881111425969">Cornea-Hebert et al., 1999</xref>; <xref ref-type="bibr" rid="bibr29-0269881111425969">Garlow et al., 1993</xref>; <xref ref-type="bibr" rid="bibr44-0269881111425969">Jakab and Goldman-Rakic, 1998</xref>; <xref ref-type="bibr" rid="bibr61-0269881111425969">Luttgen et al., 2004</xref>; <xref ref-type="bibr" rid="bibr66-0269881111425969">Martin-Ruiz et al., 2001</xref>). As in a previous study, 5-HT<sub>2A</sub>R-ir was detected in cell bodies within the septum, cells located in the pyramidal cell layers CA1-3 of the hippocampus and in the granular cell layer of the dentate gyrus as well as hippocampal interneurons (<xref ref-type="bibr" rid="bibr61-0269881111425969">Luttgen et al., 2004</xref>). 5-HT<sub>2A</sub>R-ir was also observed in the basolateral amygdala in cell bodies and some neuronal fibres as seen before (<xref ref-type="bibr" rid="bibr109-0269881111425969">Xu and Pandey, 2000</xref>). Within the cerebral cortex, 5-HT<sub>2A</sub>R was highly expressed with particular staining of cell bodies and apical dendrites of pyramidal neurons (<xref ref-type="bibr" rid="bibr108-0269881111425969">Wu et al., 1998</xref>).</p>
<p>For practical purposes only a limited number of brain regions were examined in this study. Also, it should be noted that as NK<sub>1</sub>R-positive neurons were generally sparse (except in the septum) cells were counted across whole anatomical areas rather than by using intra-region grids. As a consequence, although the percentage co-localization across regions can be compared, the data are not amenable to statistical comparisons.</p>
<p>A key finding of the present study was that NK<sub>1</sub>R-ir and 5-HT<sub>1A</sub>R-ir were co-localized to a high degree in all regions examined except for the lateral septum, with the degree of co-localization ranging from 88% (medial septum) to 31% (medial prefrontal cortex) of cells labelled with NK1R-ir in these regions. Although the study did not attempt to establish the chemical identity of the cells demonstrating co-localization of NK<sub>1</sub>Rs and 5-HT<sub>1A</sub>Rs, this is likely to vary depending on the brain region investigated. In particular, it is likely that NK<sub>1</sub>Rs and 5-HT<sub>1A</sub>Rs are co-localized on GABAergic neurons within the hippocampus, amygdala and medial prefrontal cortex. This is because although 5-HT<sub>1A</sub>Rs are located on GABAergic neurons and pyramidal neurons within these regions (<xref ref-type="bibr" rid="bibr4-0269881111425969">Aznar et al., 2003</xref>; <xref ref-type="bibr" rid="bibr36-0269881111425969">Gulyas et al., 1999</xref>), NK<sub>1</sub>Rs are found only on GABAergic neurons in the hippocampus (<xref ref-type="bibr" rid="bibr1-0269881111425969">Acsady et al., 1997</xref>; <xref ref-type="bibr" rid="bibr25-0269881111425969">Freund and Buzsaki, 1996</xref>; <xref ref-type="bibr" rid="bibr98-0269881111425969">Sloviter et al., 2001</xref>), basolateral amygdala (<xref ref-type="bibr" rid="bibr58-0269881111425969">Levita et al., 2003</xref>) and prefrontal cortex (<xref ref-type="bibr" rid="bibr48-0269881111425969">Kaneko et al., 1994</xref>). On the other hand, it is likely that NK<sub>1</sub>Rs and 5-HT<sub>1A</sub>Rs are co-localized on cholinergic neurons in the medial septum-diagonal band of Broca complex. This is because, although 5-HT<sub>1A</sub>Rs are found on cholinergic neurons (<xref ref-type="bibr" rid="bibr50-0269881111425969">Kia et al., 1996a</xref>) as well as GABAergic neurons (<xref ref-type="bibr" rid="bibr4-0269881111425969">Aznar et al., 2003</xref>) within the medial septum-diagonal band of Broca complex, NK<sub>1</sub>Rs are found only on cholinergic neurons within this region (<xref ref-type="bibr" rid="bibr11-0269881111425969">Chen et al., 2001</xref>).</p>
<p>Compared with NK<sub>1</sub>Rs and 5-HT<sub>1A</sub>Rs, the degree of co-localization between NK<sub>1</sub>Rs and 5-HT<sub>2A</sub>Rs was much less common, and this co-localization may be restricted to GABAergic neurons. This is evidenced by the fact that NK<sub>1</sub>Rs are found on GABAergic neurons within the hippocampus and amygdala, whilst 5-HT<sub>2A</sub>Rs are found on GABAergic cells as well as dendrites of excitatory granule cells within the hippocampus (<xref ref-type="bibr" rid="bibr33-0269881111425969">Geurts et al., 2002</xref>; <xref ref-type="bibr" rid="bibr45-0269881111425969">Jakab and Goldman-Rakic, 2000</xref>; <xref ref-type="bibr" rid="bibr61-0269881111425969">Luttgen et al., 2004</xref>; <xref ref-type="bibr" rid="bibr68-0269881111425969">Meltzer et al., 2003</xref>; <xref ref-type="bibr" rid="bibr84-0269881111425969">Peddie et al., 2008</xref>) and dendrites of pyramidal cells in the basolateral amygdala (<xref ref-type="bibr" rid="bibr17-0269881111425969">Cornea-Hebert et al., 1999</xref>; <xref ref-type="bibr" rid="bibr63-0269881111425969">McDonald and Mascagni, 2007</xref>; <xref ref-type="bibr" rid="bibr73-0269881111425969">Morilak et al., 1993</xref>; <xref ref-type="bibr" rid="bibr109-0269881111425969">Xu and Pandey, 2000</xref>).</p>
<p>Given the high degree of NK<sub>1</sub>R and 5-HT<sub>1A</sub>R co-localization, it is interesting that these receptors have opposing functions at the signalling level. Thus, NK<sub>1</sub>Rs are positively coupled to phospholipase C (<xref ref-type="bibr" rid="bibr39-0269881111425969">Hamke et al., 2006</xref>; <xref ref-type="bibr" rid="bibr72-0269881111425969">Mitsuhashi et al., 1992</xref>; <xref ref-type="bibr" rid="bibr75-0269881111425969">Nakajima et al., 1992</xref>; <xref ref-type="bibr" rid="bibr95-0269881111425969">Satake and Kawada, 2006</xref>) and excite neurons (<xref ref-type="bibr" rid="bibr80-0269881111425969">Page, 2005</xref>; <xref ref-type="bibr" rid="bibr85-0269881111425969">Pennefather et al., 2004</xref>), whereas 5-HT<sub>1A</sub>Rs are negatively coupled to adenylate cyclase and hyperpolarize neurons through opening G-protein-coupled K<sup>+</sup> channels (<xref ref-type="bibr" rid="bibr5-0269881111425969">Barnes and Sharp, 1999</xref>; <xref ref-type="bibr" rid="bibr43-0269881111425969">Hoyer et al., 2002</xref>). In comparison, NK<sub>1</sub>Rs and 5-HT<sub>2A</sub>Rs have complementary functions at the signalling level with 5-HT<sub>2A</sub>Rs, like NK<sub>1</sub>Rs, being positively coupled to phospholipase C and bringing about neuronal excitation (see <xref ref-type="bibr" rid="bibr5-0269881111425969">Barnes and Sharp, 1999</xref>).</p>
<p>The above predicts that 5-HT<sub>1A</sub>R agonists, NK<sub>1</sub>R antagonists and 5-HT<sub>2A</sub>R antagonists may have similar functional effects and there is both electrophysiological and behavioural evidence to support this. For example, the 5-HT<sub>1A</sub>R agonist 8-OH-DPAT inhibited the firing rate of hippocampal neurons (<xref ref-type="bibr" rid="bibr99-0269881111425969">Stein et al., 2000</xref>; <xref ref-type="bibr" rid="bibr105-0269881111425969">Wang et al., 1999</xref>), whereas the NK<sub>1</sub>R antagonist SR140,333 suppressed Substance P-induced excitation of hippocampal neurons (<xref ref-type="bibr" rid="bibr20-0269881111425969">Dreifuss and Raggenbass, 1986</xref>; <xref ref-type="bibr" rid="bibr102-0269881111425969">Teixeira et al., 1996</xref>). Also, local infusions of 5-HT<sub>1A</sub>R agonists into the septum reversed helpless behaviour on the learned helplessness paradigm (<xref ref-type="bibr" rid="bibr65-0269881111425969">Martin et al., 1991</xref>) and the forced swim test (<xref ref-type="bibr" rid="bibr96-0269881111425969">Schreiber and De Vry, 1993</xref>). The latter study specifically investigated infusions into the lateral septum. A more recent study showed that local administration of the NK<sub>1</sub>R antagonist L-822429 into the lateral septum reduced passive and facilitated active stress-coping strategies in the forced swim test (<xref ref-type="bibr" rid="bibr22-0269881111425969">Ebner et al., 2008</xref>). The investigators suggested that this effect was mediated via increased 5-HT neurotransmission as it was blocked by intraseptal 5-HT<sub>1A</sub>R antagonism. They also showed that NK<sub>1</sub>Rs were located on calbindin-positive neurons, suggesting the involvement of GABAergic interneurons in this interaction (<xref ref-type="bibr" rid="bibr22-0269881111425969">Ebner et al., 2008</xref>). In concordance with the results of the latter study, we did not find significant co-localization between NK<sub>1</sub>Rs and 5-HT<sub>1A</sub>Rs in the lateral septum in our study. However, we suggest that the high percentage of co-localization in the medial septum is worth further investigation as functional studies with NK<sub>1</sub>R antagonists in this brain region may show much more powerful effects than those observed in the lateral septum.</p>
<p>Studies in the amygdala showed that local infusions of 5-HT<sub>1A</sub>R agonists into the basolateral amygdala had anxiolytic effects as measured on the elevated T-maze (<xref ref-type="bibr" rid="bibr110-0269881111425969">Zangrossi et al., 1999</xref>), and the contextual conditioned freezing test (<xref ref-type="bibr" rid="bibr59-0269881111425969">Li et al., 2006</xref>). Similar observations of anxiolysis have been made following local infusion of 5-HT<sub>2</sub>R antagonists (<xref ref-type="bibr" rid="bibr42-0269881111425969">Hodges et al., 1987</xref>) or NK<sub>1</sub>R antagonists (<xref ref-type="bibr" rid="bibr7-0269881111425969">Boyce et al., 2001</xref>; <xref ref-type="bibr" rid="bibr21-0269881111425969">Ebner and Singewald, 2006</xref>).</p>
<p>The above animal studies resonate with the findings of the clinical effects of 5-HT<sub>1A</sub>R agonists, NK<sub>1</sub>R antagonists and 5-HT<sub>2A</sub>R antagonists. For example, initial phase II trials showed benefits over placebo for NK<sub>1</sub>R antagonist aprepitant (<xref ref-type="bibr" rid="bibr54-0269881111425969">Kramer et al., 1998</xref>) with antidepressant efficacy also being observed with the NK<sub>1</sub>R antagonists L-759274 (Compound A) (<xref ref-type="bibr" rid="bibr55-0269881111425969">Kramer et al., 2004</xref>) and CP-122721 (<xref ref-type="bibr" rid="bibr10-0269881111425969">Chappell, 2002</xref>). In a similar way, the 5-HT<sub>1A</sub>R agonist buspirone (<xref ref-type="bibr" rid="bibr91-0269881111425969">Rush et al., 2009</xref>) and atypical antipsychotics with 5-HT<sub>2</sub>R blocking properties (<xref ref-type="bibr" rid="bibr24-0269881111425969">Fontaine, 1993</xref>; <xref ref-type="bibr" rid="bibr70-0269881111425969">Millan, 2003</xref>; <xref ref-type="bibr" rid="bibr78-0269881111425969">Olver et al., 2008</xref>) have been shown to effectively augment the action of antidepressants.</p>
<p>In conclusion, the present study observed significant degrees of co-localization between NK<sub>1</sub>Rs and 5-HT<sub>1A</sub>Rs in rat forebrain regions, as well as a more restricted level of co-localization between NK<sub>1</sub>Rs and 5-HT<sub>2A</sub>Rs. These results suggest a novel cellular substrate for interactions between NK<sub>1</sub>R antagonists and the 5-HT system. On the basis of known signalling effects of NK<sub>1</sub>Rs, 5-HT<sub>1A</sub>Rs and 5-HT<sub>2A</sub>Rs, there is an interesting prediction that NK<sub>1</sub>R antagonists might have similar functional effects to 5-HT<sub>1A</sub>R agonists and 5-HT<sub>2A</sub>R antagonists, and there is evidence to support this in some preclinical and clinical studies.</p>
</sec>
</body>
<back>
<sec id="section14-0269881111425969">
<title>Funding</title>
<p>This work was supported by the Medical Research Council (UK) with a Clinical Research Training Fellowship to SH.</p>
</sec>
<sec id="section15-0269881111425969">
<title>Conflict of interest</title>
<p>None declared.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Acsady</surname><given-names>L</given-names></name>
<name><surname>Katona</surname><given-names>I</given-names></name>
<name><surname>Gulyas</surname><given-names>AI</given-names></name>
<etal/>
</person-group>. (<year>1997</year>) <article-title>Immunostaining for substance P receptor labels GABAergic cells with distinct termination patterns in the hippocampus</article-title>. <source>J Comp Neurol</source> <volume>378</volume>: <fpage>320</fpage>â<lpage>336</lpage>.</citation>
</ref>
<ref id="bibr2-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Anthony</surname><given-names>TE</given-names></name>
<name><surname>Azmitia</surname><given-names>EC</given-names></name>
</person-group> (<year>1997</year>) <article-title>Molecular characterization of antipeptide antibodies against the 5-HT1A receptor: evidence for state-dependent antibody binding</article-title>. <source>Brain Res Mol Brain Res</source> <volume>50</volume>: <fpage>277</fpage>â<lpage>284</lpage>.</citation>
</ref>
<ref id="bibr3-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Azmitia</surname><given-names>EC</given-names></name>
<name><surname>Yu</surname><given-names>I</given-names></name>
<name><surname>Akbari</surname><given-names>HM</given-names></name>
<etal/>
</person-group>. (<year>1992</year>) <article-title>Antipeptide antibodies against the 5-HT1A receptor</article-title>. <source>J Chem Neuroanat</source> <volume>5</volume>: <fpage>289</fpage>â<lpage>298</lpage>.</citation>
</ref>
<ref id="bibr4-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aznar</surname><given-names>S</given-names></name>
<name><surname>Qian</surname><given-names>Z</given-names></name>
<name><surname>Shah</surname><given-names>R</given-names></name>
<etal/>
</person-group>. (<year>2003</year>) <article-title>The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain</article-title>. <source>Brain Res</source> <volume>959</volume>: <fpage>58</fpage>â<lpage>67</lpage>.</citation>
</ref>
<ref id="bibr5-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barnes</surname><given-names>NM</given-names></name>
<name><surname>Sharp</surname><given-names>T</given-names></name>
</person-group> (<year>1999</year>) <article-title>A review of central 5-HT receptors and their function</article-title>. <source>Neuropharmacology</source> <volume>38</volume>: <fpage>1083</fpage>â<lpage>1152</lpage>.</citation>
</ref>
<ref id="bibr6-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blier</surname><given-names>P</given-names></name>
<name><surname>Gobbi</surname><given-names>G</given-names></name>
<name><surname>Haddjeri</surname><given-names>N</given-names></name>
<etal/>
</person-group>. (<year>2004</year>) <article-title>Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response</article-title>. <source>J Psychiatry Neurosci</source> <volume>29</volume>: <fpage>208</fpage>â<lpage>218</lpage>.</citation>
</ref>
<ref id="bibr7-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boyce</surname><given-names>S</given-names></name>
<name><surname>Smith</surname><given-names>D</given-names></name>
<name><surname>Carlson</surname><given-names>E</given-names></name>
<etal/>
</person-group>. (<year>2001</year>) <article-title>Intra-amygdala injection of the substance P [NK(1) receptor] antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs</article-title>. <source>Neuropharmacology</source> <volume>41</volume>: <fpage>130</fpage>â<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr8-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burnet</surname><given-names>PW</given-names></name>
<name><surname>Harrison</surname><given-names>PJ</given-names></name>
</person-group> (<year>2000</year>) <article-title>Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia</article-title>. <source>Biol Psychiatry</source> <volume>47</volume>: <fpage>80</fpage>â<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr9-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carletti</surname><given-names>R</given-names></name>
<name><surname>Corsi</surname><given-names>M</given-names></name>
<name><surname>Melotto</surname><given-names>S</given-names></name>
<etal/>
</person-group>. (<year>2005</year>) <article-title>Down-regulation of amygdala preprotachykinin A mRNA but not H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia</article-title>. <source>Eur J Neurosci</source> <volume>21</volume>: <fpage>1712</fpage>â<lpage>1718</lpage>.</citation>
</ref>
<ref id="bibr10-0269881111425969">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Chappell</surname><given-names>P</given-names></name>
</person-group> (<year>2002</year>) <article-title>Effects of CP-122,721, a selective NK-1 receptor antagonist in patients with major depression</article-title>. <conf-name>42nd Annual Meeting of the New Clinical Drug Evaluation Unit (NCDEU)</conf-name>. <conf-loc>Boca Raton, FL</conf-loc>.</citation>
</ref>
<ref id="bibr11-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>LW</given-names></name>
<name><surname>Wei</surname><given-names>LC</given-names></name>
<name><surname>Liu</surname><given-names>HL</given-names></name>
<etal/>
</person-group>. (<year>2001</year>) <article-title>Cholinergic neurons expressing substance P receptor (NK(1)) in the basal forebrain of the rat: a double immunocytochemical study</article-title>. <source>Brain Res</source> <volume>904</volume>: <fpage>161</fpage>â<lpage>166</lpage>.</citation>
</ref>
<ref id="bibr12-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clement</surname><given-names>Y</given-names></name>
<name><surname>Kia</surname><given-names>KH</given-names></name>
<name><surname>Daval</surname><given-names>G</given-names></name>
<etal/>
</person-group>. (<year>1996</year>) <article-title>An autoradiographic study of serotonergic receptors in a murine genetic model of anxiety-related behaviors</article-title>. <source>Brain Res</source> <volume>709</volume>: <fpage>229</fpage>â<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr13-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Collin</surname><given-names>M</given-names></name>
<name><surname>Backberg</surname><given-names>M</given-names></name>
<name><surname>Onnestam</surname><given-names>K</given-names></name>
<etal/>
</person-group>. (<year>2002</year>) <article-title>5-HT1A receptor immunoreactivity in hypothalamic neurons involved in body weight control</article-title>. <source>Neuroreport</source> <volume>13</volume>: <fpage>945</fpage>â<lpage>951</lpage>.</citation>
</ref>
<ref id="bibr14-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Commons</surname><given-names>KG</given-names></name>
</person-group> (<year>2010</year>) <article-title>Neuronal pathways linking substance P to drug addiction and stress</article-title>. <source>Brain Res</source> <volume>1314</volume>: <fpage>175</fpage>â<lpage>182</lpage>.</citation>
</ref>
<ref id="bibr15-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Commons</surname><given-names>KG</given-names></name>
<name><surname>Connolley</surname><given-names>KR</given-names></name>
<name><surname>Valentino</surname><given-names>RJ</given-names></name>
</person-group> (<year>2003</year>) <article-title>A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders</article-title>. <source>Neuropsychopharmacology</source> <volume>28</volume>: <fpage>206</fpage>â<lpage>215</lpage>.</citation>
</ref>
<ref id="bibr16-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Conley</surname><given-names>RK</given-names></name>
<name><surname>Cumberbatch</surname><given-names>MJ</given-names></name>
<name><surname>Mason</surname><given-names>GS</given-names></name>
<etal/>
</person-group>. (<year>2002</year>) <article-title>Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity</article-title>. <source>J Neurosci</source> <volume>22</volume>: <fpage>7730</fpage>â<lpage>7736</lpage>.</citation>
</ref>
<ref id="bibr17-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cornea-Hebert</surname><given-names>V</given-names></name>
<name><surname>Riad</surname><given-names>M</given-names></name>
<name><surname>Wu</surname><given-names>C</given-names></name>
<etal/>
</person-group>. (<year>1999</year>) <article-title>Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat</article-title>. <source>J Comp Neurol</source> <volume>409</volume>: <fpage>187</fpage>â<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr18-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Czyrak</surname><given-names>A</given-names></name>
<name><surname>Czepiel</surname><given-names>K</given-names></name>
<name><surname>Mackowiak</surname><given-names>M</given-names></name>
<etal/>
</person-group>. (<year>2003</year>) <article-title>Serotonin 5-HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex</article-title>. <source>Brain Res</source> <volume>989</volume>: <fpage>42</fpage>â<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr19-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Doherty</surname><given-names>MD</given-names></name>
<name><surname>Pickel</surname><given-names>VM</given-names></name>
</person-group> (<year>2000</year>) <article-title>Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area</article-title>. <source>Brain Res</source> <volume>864</volume>: <fpage>176</fpage>â<lpage>185</lpage>.</citation>
</ref>
<ref id="bibr20-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dreifuss</surname><given-names>JJ</given-names></name>
<name><surname>Raggenbass</surname><given-names>M</given-names></name>
</person-group> (<year>1986</year>) <article-title>Tachykinins and bombesin excite non-pyramidal neurones in rat hippocampus</article-title>. <source>J Physiol</source> <volume>379</volume>: <fpage>417</fpage>â<lpage>428</lpage>.</citation>
</ref>
<ref id="bibr21-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ebner</surname><given-names>K</given-names></name>
<name><surname>Singewald</surname><given-names>N</given-names></name>
</person-group> (<year>2006</year>) <article-title>The role of substance P in stress and anxiety responses</article-title>. <source>Amino Acids</source> <volume>31</volume>: <fpage>251</fpage>â<lpage>272</lpage>.</citation>
</ref>
<ref id="bibr22-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ebner</surname><given-names>K</given-names></name>
<name><surname>Singewald</surname><given-names>GM</given-names></name>
<name><surname>Whittle</surname><given-names>N</given-names></name>
<etal/>
</person-group>. (<year>2008</year>) <article-title>Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission</article-title>. <source>Neuropsychopharmacology</source> <volume>33</volume>: <fpage>1929</fpage>â<lpage>1941</lpage>.</citation>
</ref>
<ref id="bibr23-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ebner</surname><given-names>K</given-names></name>
<name><surname>Sartori</surname><given-names>SB</given-names></name>
<name><surname>Singewald</surname><given-names>N</given-names></name>
</person-group> (<year>2009</year>) <article-title>Tachykinin receptors as therapeutic targets in stress-related disorders</article-title>. <source>Curr Pharm Des</source> <volume>15</volume>: <fpage>1647</fpage>â<lpage>1674</lpage>.</citation>
</ref>
<ref id="bibr24-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fontaine</surname><given-names>R</given-names></name>
</person-group> (<year>1993</year>) <article-title>Novel serotonergic mechanisms and clinical experience with nefazodone</article-title>. <source>Clin Neuropharmacol</source> <volume>16</volume>(<supplement>Suppl. 3</supplement>): <fpage>S45</fpage>â<lpage>S50</lpage>.</citation>
</ref>
<ref id="bibr25-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Freund</surname><given-names>TF</given-names></name>
<name><surname>Buzsaki</surname><given-names>G</given-names></name>
</person-group> (<year>1996</year>) <article-title>Interneurons of the hippocampus</article-title>. <source>Hippocampus</source> <volume>6</volume>: <fpage>347</fpage>â<lpage>470</lpage>.</citation>
</ref>
<ref id="bibr26-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Froger</surname><given-names>N</given-names></name>
<name><surname>Gardier</surname><given-names>AM</given-names></name>
<name><surname>Moratalla</surname><given-names>R</given-names></name>
<etal/>
</person-group>. (<year>2001</year>) <article-title>5-Hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization</article-title>. <source>J Neurosci</source> <volume>21</volume>: <fpage>8188</fpage>-<lpage>8197</lpage>.</citation>
</ref>
<ref id="bibr27-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fujimura</surname><given-names>Y</given-names></name>
<name><surname>Yasuno</surname><given-names>F</given-names></name>
<name><surname>Farris</surname><given-names>A</given-names></name>
<etal/>
</person-group>. (<year>2009</year>) <article-title>Decreased neurokinin-1 (substance P) receptor binding in patients with panic disorder: positron emission tomographic study with [18F]SPA-RQ</article-title>. <source>Biol Psychiatry</source> <volume>66</volume>: <fpage>94</fpage>â<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr28-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Furmark</surname><given-names>T</given-names></name>
<name><surname>Appel</surname><given-names>L</given-names></name>
<name><surname>Michelgard</surname><given-names>A</given-names></name>
<etal/>
</person-group>. (<year>2005</year>) <article-title>Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo</article-title>. <source>Biol Psychiatry</source> <volume>58</volume>: <fpage>132</fpage>â<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr29-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garlow</surname><given-names>SJ</given-names></name>
<name><surname>Morilak</surname><given-names>DA</given-names></name>
<name><surname>Dean</surname><given-names>RR</given-names></name>
<etal/>
</person-group>. (<year>1993</year>) <article-title>Production and characterization of a specific 5-HT2 receptor antibody</article-title>. <source>Brain Res</source> <volume>615</volume>: <fpage>113</fpage>â<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr30-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>George</surname><given-names>DT</given-names></name>
<name><surname>Gilman</surname><given-names>J</given-names></name>
<name><surname>Hersh</surname><given-names>J</given-names></name>
<etal/>
</person-group>. (<year>2008</year>) <article-title>Neurokinin 1 receptor antagonism as a possible therapy for alcoholism</article-title>. <source>Science</source> <volume>319</volume>: <fpage>1536</fpage>â<lpage>1539</lpage>.</citation>
</ref>
<ref id="bibr31-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Geracioti</surname><given-names>TD</given-names><suffix>Jr</suffix></name>
<name><surname>Carpenter</surname><given-names>LL</given-names></name>
<name><surname>Owens</surname><given-names>MJ</given-names></name>
<etal/>
</person-group>. (<year>2006</year>) <article-title>Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression</article-title>. <source>Am J Psychiatry</source> <volume>163</volume>: <fpage>637</fpage>â<lpage>643</lpage>.</citation>
</ref>
<ref id="bibr32-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gerard</surname><given-names>C</given-names></name>
<name><surname>Langlois</surname><given-names>X</given-names></name>
<name><surname>Gingrich</surname><given-names>J</given-names></name>
<etal/>
</person-group>. (<year>1994</year>) <article-title>Production and characterization of polyclonal antibodies recognizing the intracytoplasmic third loop of the 5-hydroxytryptamine1A receptor</article-title>. <source>Neuroscience</source> <volume>62</volume>: <fpage>721</fpage>â<lpage>739</lpage>.</citation>
</ref>
<ref id="bibr33-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Geurts</surname><given-names>FJ</given-names></name>
<name><surname>De Schutter</surname><given-names>E</given-names></name>
<name><surname>Timmermans</surname><given-names>JP</given-names></name>
</person-group> (<year>2002</year>) <article-title>Localization of 5-HT2A, 5-HT3, 5-HT5A and 5-HT7 receptor-like immunoreactivity in the rat cerebellum</article-title>. <source>J Chem Neuroanat</source> <volume>24</volume>: <fpage>65</fpage>â<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr34-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gobbi</surname><given-names>G</given-names></name>
<name><surname>Cassano</surname><given-names>T</given-names></name>
<name><surname>Radja</surname><given-names>F</given-names></name>
<etal/>
</person-group>. (<year>2007</year>) <article-title>Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function</article-title>. <source>Eur Neuropsychopharmacol</source> <volume>17</volume>: <fpage>328</fpage>â<lpage>338</lpage>.</citation>
</ref>
<ref id="bibr35-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guiard</surname><given-names>BP</given-names></name>
<name><surname>Froger</surname><given-names>N</given-names></name>
<name><surname>Hamon</surname><given-names>M</given-names></name>
<etal/>
</person-group>. (<year>2005</year>) <article-title>Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice</article-title>. <source>J Neurochem</source> <volume>95</volume>: <fpage>1713</fpage>â<lpage>1723</lpage>.</citation>
</ref>
<ref id="bibr36-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gulyas</surname><given-names>AI</given-names></name>
<name><surname>Acsady</surname><given-names>L</given-names></name>
<name><surname>Freund</surname><given-names>TF</given-names></name>
</person-group> (<year>1999</year>) <article-title>Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus</article-title>. <source>Neurochem Int</source> <volume>34</volume>: <fpage>359</fpage>â<lpage>372</lpage>.</citation>
</ref>
<ref id="bibr37-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Haddjeri</surname><given-names>N</given-names></name>
<name><surname>Blier</surname><given-names>P</given-names></name>
</person-group> (<year>2001</year>) <article-title>Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission</article-title>. <source>Biol Psychiatry</source> <volume>50</volume>: <fpage>191</fpage>â<lpage>199</lpage>.</citation>
</ref>
<ref id="bibr38-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hahn</surname><given-names>MK</given-names></name>
<name><surname>Bannon</surname><given-names>MJ</given-names></name>
</person-group> (<year>1999</year>) <article-title>Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation</article-title>. <source>Neuroscience</source> <volume>94</volume>: <fpage>1183</fpage>â<lpage>1188</lpage>.</citation>
</ref>
<ref id="bibr39-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hamke</surname><given-names>M</given-names></name>
<name><surname>Herpfer</surname><given-names>I</given-names></name>
<name><surname>Lieb</surname><given-names>K</given-names></name>
<etal/>
</person-group>. (<year>2006</year>) <article-title>Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor</article-title>. <source>Brain Res</source> <volume>1102</volume>: <fpage>135</fpage>â<lpage>144</lpage>.</citation>
</ref>
<ref id="bibr40-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heilig</surname><given-names>M</given-names></name>
<name><surname>Thorsell</surname><given-names>A</given-names></name>
<name><surname>Sommer</surname><given-names>WH</given-names></name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues</article-title>. <source>Neurosci Biobehav Rev</source> <volume>35</volume>: <fpage>334</fpage>â<lpage>344</lpage>.</citation>
</ref>
<ref id="bibr41-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Herpfer</surname><given-names>I</given-names></name>
<name><surname>Hunt</surname><given-names>SP</given-names></name>
<name><surname>Stanford</surname><given-names>SC</given-names></name>
</person-group> (<year>2005</year>) <article-title>A comparison of neurokinin 1 receptor knock-out (NK1â/â) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects</article-title>. <source>Neuropharmacology</source> <volume>48</volume>: <fpage>706</fpage>â<lpage>719</lpage>.</citation>
</ref>
<ref id="bibr42-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hodges</surname><given-names>H</given-names></name>
<name><surname>Green</surname><given-names>S</given-names></name>
<name><surname>Glenn</surname><given-names>B</given-names></name>
</person-group> (<year>1987</year>) <article-title>Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination</article-title>. <source>Psychopharmacology (Berl)</source> <volume>92</volume>: <fpage>491</fpage>â<lpage>504</lpage>.</citation>
</ref>
<ref id="bibr43-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hoyer</surname><given-names>D</given-names></name>
<name><surname>Hannon</surname><given-names>JP</given-names></name>
<name><surname>Martin</surname><given-names>GR</given-names></name>
</person-group> (<year>2002</year>) <article-title>Molecular, pharmacological and functional diversity of 5-HT receptors</article-title>. <source>Pharmacol Biochem Behav</source> <volume>71</volume>: <fpage>533</fpage>â<lpage>554</lpage>.</citation>
</ref>
<ref id="bibr44-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jakab</surname><given-names>RL</given-names></name>
<name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name>
</person-group> (<year>1998</year>) <article-title>5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>95</volume>: <fpage>735</fpage>â<lpage>740</lpage>.</citation>
</ref>
<ref id="bibr45-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jakab</surname><given-names>RL</given-names></name>
<name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name>
</person-group> (<year>2000</year>) <article-title>Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex</article-title>. <source>J Comp Neurol</source> <volume>417</volume>: <fpage>337</fpage>â<lpage>348</lpage>.</citation>
</ref>
<ref id="bibr46-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jansson</surname><given-names>A</given-names></name>
<name><surname>Tinner</surname><given-names>B</given-names></name>
<name><surname>Steinbusch</surname><given-names>HW</given-names></name>
<etal/>
</person-group>. (<year>1998</year>) <article-title>On the relationship of 5-hydroxytryptamine neurons to 5-hydroxytryptamine 2A receptor-immunoreactive neuronal processes in the brain stem of rats. A double immunolabelling analysis</article-title>. <source>Neuroreport</source> <volume>9</volume>: <fpage>2505</fpage>â<lpage>2511</lpage>.</citation>
</ref>
<ref id="bibr47-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jansson</surname><given-names>A</given-names></name>
<name><surname>Tinner</surname><given-names>B</given-names></name>
<name><surname>Bancila</surname><given-names>M</given-names></name>
<etal/>
</person-group>. (<year>2001</year>) <article-title>Relationships of 5-hydroxytryptamine immunoreactive terminal-like varicosities to 5-hydroxytryptamine-2A receptor-immunoreactive neuronal processes in the rat forebrain</article-title>. <source>J Chem Neuroanat</source> <volume>22</volume>: <fpage>185</fpage>â<lpage>203</lpage>.</citation>
</ref>
<ref id="bibr48-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaneko</surname><given-names>T</given-names></name>
<name><surname>Shigemoto</surname><given-names>R</given-names></name>
<name><surname>Nakanishi</surname><given-names>S</given-names></name>
<etal/>
</person-group>. (<year>1994</year>) <article-title>Morphological and chemical characteristics of substance P receptor-immunoreactive neurons in the rat neocortex</article-title>. <source>Neuroscience</source> <volume>60</volume>: <fpage>199</fpage>-<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr49-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Keller</surname><given-names>M</given-names></name>
<name><surname>Montgomery</surname><given-names>S</given-names></name>
<name><surname>Ball</surname><given-names>W</given-names></name>
<etal/>
</person-group>. (<year>2006</year>) <article-title>Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder</article-title>. <source>Biol Psychiatry</source> <volume>59</volume>: <fpage>216</fpage>â<lpage>223</lpage>.</citation>
</ref>
<ref id="bibr50-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kia</surname><given-names>HK</given-names></name>
<name><surname>Brisorgueil</surname><given-names>MJ</given-names></name>
<name><surname>Daval</surname><given-names>G</given-names></name>
<etal/>
</person-group>. (<year>1996a</year>) <article-title>Serotonin1A receptors are expressed by a subpopulation of cholinergic neurons in the rat medial septum and diagonal band of Broca â a double immunocytochemical study</article-title>. <source>Neuroscience</source> <volume>74</volume>: <fpage>143</fpage>â<lpage>154</lpage>.</citation>
</ref>
<ref id="bibr51-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kia</surname><given-names>HK</given-names></name>
<name><surname>Brisorgueil</surname><given-names>MJ</given-names></name>
<name><surname>Hamon</surname><given-names>M</given-names></name>
<etal/>
</person-group>. (<year>1996b</year>) <article-title>Ultrastructural localization of 5-hydroxytryptamine1A receptors in the rat brain</article-title>. <source>J Neurosci Res</source> <volume>46</volume>: <fpage>697</fpage>â<lpage>708</lpage>.</citation>
</ref>
<ref id="bibr52-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kia</surname><given-names>HK</given-names></name>
<name><surname>Miquel</surname><given-names>MC</given-names></name>
<name><surname>Brisorgueil</surname><given-names>MJ</given-names></name>
<etal/>
</person-group>. (<year>1996c</year>) <article-title>Immunocytochemical localization of serotonin1A receptors in the rat central nervous system</article-title>. <source>J Comp Neurol</source> <volume>365</volume>: <fpage>289</fpage>â<lpage>305</lpage>.</citation>
</ref>
<ref id="bibr53-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>DS</given-names></name>
<name><surname>Kim</surname><given-names>JE</given-names></name>
<name><surname>Kwak</surname><given-names>SE</given-names></name>
<etal/>
</person-group>. (<year>2007</year>) <article-title>Seizure activity selectively reduces 5-HT1A receptor immunoreactivity in CA1 interneurons in the hippocampus of seizure-prone gerbils</article-title>. <source>Brain Res</source> <volume>1154</volume>: <fpage>181</fpage>â<lpage>193</lpage>.</citation>
</ref>
<ref id="bibr54-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kramer</surname><given-names>MS</given-names></name>
<name><surname>Cutler</surname><given-names>N</given-names></name>
<name><surname>Feighner</surname><given-names>J</given-names></name>
<etal/>
</person-group>. (<year>1998</year>) <article-title>Distinct mechanism for antidepressant activity by blockade of central substance P receptors</article-title>. <source>Science</source> <volume>281</volume>: <fpage>1640</fpage>â<lpage>1645</lpage>.</citation>
</ref>
<ref id="bibr55-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kramer</surname><given-names>MS</given-names></name>
<name><surname>Winokur</surname><given-names>A</given-names></name>
<name><surname>Kelsey</surname><given-names>J</given-names></name>
<etal/>
</person-group>. (<year>2004</year>) <article-title>Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression</article-title>. <source>Neuropsychopharmacology</source> <volume>29</volume>: <fpage>385</fpage>â<lpage>392</lpage>.</citation>
</ref>
<ref id="bibr56-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lacoste</surname><given-names>B</given-names></name>
<name><surname>Riad</surname><given-names>M</given-names></name>
<name><surname>Descarries</surname><given-names>L</given-names></name>
</person-group> (<year>2006</year>) <article-title>Immunocytochemical evidence for the existence of substance P receptor (NK1) in serotonin neurons of rat and mouse dorsal raphe nucleus</article-title>. <source>Eur J Neurosci</source> <volume>23</volume>: <fpage>2947</fpage>â<lpage>2958</lpage>.</citation>
</ref>
<ref id="bibr57-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lacoste</surname><given-names>B</given-names></name>
<name><surname>Riad</surname><given-names>M</given-names></name>
<name><surname>Ratte</surname><given-names>MO</given-names></name>
<etal/>
</person-group>. (<year>2009</year>) <article-title>Trafficking of neurokinin-1 receptors in serotonin neurons is controlled by substance P within the rat dorsal raphe nucleus</article-title>. <source>Eur J Neurosci</source> <volume>29</volume>: <fpage>2303</fpage>â<lpage>2314</lpage>.</citation>
</ref>
<ref id="bibr58-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Levita</surname><given-names>L</given-names></name>
<name><surname>Mania</surname><given-names>I</given-names></name>
<name><surname>Rainnie</surname><given-names>DG</given-names></name>
</person-group> (<year>2003</year>) <article-title>Subtypes of substance P receptor immunoreactive interneurons in the rat basolateral amygdala</article-title>. <source>Brain Res</source> <volume>981</volume>: <fpage>41</fpage>â<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr59-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>X</given-names></name>
<name><surname>Inoue</surname><given-names>T</given-names></name>
<name><surname>Abekawa</surname><given-names>T</given-names></name>
<etal/>
</person-group>. (<year>2006</year>) <article-title>5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala</article-title>. <source>Eur J Pharmacol</source> <volume>532</volume>: <fpage>74</fpage>â<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr60-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>HL</given-names></name>
<name><surname>Cao</surname><given-names>R</given-names></name>
<name><surname>Jin</surname><given-names>L</given-names></name>
<etal/>
</person-group>. (<year>2002</year>) <article-title>Immunocytochemical localization of substance P receptor in hypothalamic oxytocin-containing neurons of C57 mice</article-title>. <source>Brain Res</source> <volume>948</volume>: <fpage>175</fpage>â<lpage>179</lpage>.</citation>
</ref>
<ref id="bibr61-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Luttgen</surname><given-names>M</given-names></name>
<name><surname>Ove Ogren</surname><given-names>S</given-names></name>
<name><surname>Meister</surname><given-names>B</given-names></name>
</person-group> (<year>2004</year>) <article-title>Chemical identity of 5-HT(2A) receptor immunoreactive neurons of the rat septal complex and dorsal hippocampus</article-title>. <source>Brain Res</source> <volume>1010</volume>: <fpage>156</fpage>â<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr62-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Luttgen</surname><given-names>M</given-names></name>
<name><surname>Ogren</surname><given-names>SO</given-names></name>
<name><surname>Meister</surname><given-names>B</given-names></name>
</person-group> (<year>2005</year>) <article-title>5-HT(1A) receptor mRNA and immunoreactivity in the rat medial septum/diagonal band of Broca-relationships to GABAergic and cholinergic neurons</article-title>. <source>J Chem Neuroanat</source> <volume>29</volume>: <fpage>93</fpage>â<lpage>111</lpage>.</citation>
</ref>
<ref id="bibr63-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McDonald</surname><given-names>AJ</given-names></name>
<name><surname>Mascagni</surname><given-names>F</given-names></name>
</person-group> (<year>2007</year>) <article-title>Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala</article-title>. <source>Neuroscience</source> <volume>146</volume>: <fpage>306</fpage>â<lpage>320</lpage>.</citation>
</ref>
<ref id="bibr64-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mantyh</surname><given-names>PW</given-names></name>
<name><surname>Hunt</surname><given-names>SP</given-names></name>
<name><surname>Maggio</surname><given-names>JE</given-names></name>
</person-group>. (<year>1984</year>) <article-title>Substance P receptors: localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand</article-title>. <source>Brain Res</source> <volume>307</volume>: <fpage>147</fpage>â<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr65-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martin</surname><given-names>P</given-names></name>
<name><surname>Tissier</surname><given-names>MH</given-names></name>
<name><surname>Adrien</surname><given-names>J</given-names></name>
<etal/>
</person-group>. (<year>1991</year>) <article-title>Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigm</article-title>. <source>Life Sci</source> <volume>48</volume>: <fpage>2505</fpage>â<lpage>2511</lpage>.</citation>
</ref>
<ref id="bibr66-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martin-Ruiz</surname><given-names>R</given-names></name>
<name><surname>Puig</surname><given-names>MV</given-names></name>
<name><surname>Celada</surname><given-names>P</given-names></name>
<etal/>
</person-group>. (<year>2001</year>) <article-title>Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism</article-title>. <source>J Neurosci</source> <volume>21</volume>: <fpage>9856</fpage>â<lpage>9866</lpage>.</citation>
</ref>
<ref id="bibr67-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maubach</surname><given-names>KA</given-names></name>
<name><surname>Martin</surname><given-names>K</given-names></name>
<name><surname>Chicchi</surname><given-names>G</given-names></name>
<etal/>
</person-group>. (<year>2002</year>) <article-title>Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus</article-title>. <source>Neuroscience</source> <volume>109</volume>: <fpage>609</fpage>â<lpage>617</lpage>.</citation>
</ref>
<ref id="bibr68-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meltzer</surname><given-names>HY</given-names></name>
<name><surname>Li</surname><given-names>Z</given-names></name>
<name><surname>Kaneda</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. (<year>2003</year>) <article-title>Serotonin receptors: their key role in drugs to treat schizophrenia</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source> <volume>27</volume>: <fpage>1159</fpage>â<lpage>1172</lpage>.</citation>
</ref>
<ref id="bibr69-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Michelgard</surname><given-names>A</given-names></name>
<name><surname>Appel</surname><given-names>L</given-names></name>
<name><surname>Pissiota</surname><given-names>A</given-names></name>
<etal/>
</person-group>. (<year>2007</year>) <article-title>Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor system</article-title>. <source>Biol Psychiatry</source> <volume>61</volume>: <fpage>1002</fpage>â<lpage>1006</lpage>.</citation>
</ref>
<ref id="bibr70-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Millan</surname><given-names>MJ</given-names></name>
</person-group> (<year>2003</year>) <article-title>The neurobiology and control of anxious states</article-title>. <source>Prog Neurobiol</source> <volume>70</volume>: <fpage>83</fpage>â<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr71-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miner</surname><given-names>LA</given-names></name>
<name><surname>Backstrom</surname><given-names>JR</given-names></name>
<name><surname>Sanders-Bush</surname><given-names>E</given-names></name>
<etal/>
</person-group>. (<year>2003</year>) <article-title>Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex</article-title>. <source>Neuroscience</source> <volume>116</volume>: <fpage>107</fpage>â<lpage>117</lpage>.</citation>
</ref>
<ref id="bibr72-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mitsuhashi</surname><given-names>M</given-names></name>
<name><surname>Ohashi</surname><given-names>Y</given-names></name>
<name><surname>Shichijo</surname><given-names>S</given-names></name>
<etal/>
</person-group>. (<year>1992</year>) <article-title>Multiple intracellular signaling pathways of the neuropeptide substance P receptor</article-title>. <source>J Neurosci Res</source> <volume>32</volume>: <fpage>437</fpage>â<lpage>443</lpage>.</citation>
</ref>
<ref id="bibr73-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morilak</surname><given-names>DA</given-names></name>
<name><surname>Garlow</surname><given-names>SJ</given-names></name>
<name><surname>Ciaranello</surname><given-names>RD</given-names></name>
</person-group> (<year>1993</year>) <article-title>Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain</article-title>. <source>Neuroscience</source> <volume>54</volume>: <fpage>701</fpage>â<lpage>717</lpage>.</citation>
</ref>
<ref id="bibr74-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Myohanen</surname><given-names>TT</given-names></name>
<name><surname>Venalainen</surname><given-names>JI</given-names></name>
<name><surname>Garcia-Horsman</surname><given-names>JA</given-names></name>
<etal/>
</person-group>. (<year>2008</year>) <article-title>Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study</article-title>. <source>Neuroscience</source> <volume>153</volume>: <fpage>1177</fpage>â<lpage>1189</lpage>.</citation>
</ref>
<ref id="bibr75-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakajima</surname><given-names>Y</given-names></name>
<name><surname>Tsuchida</surname><given-names>K</given-names></name>
<name><surname>Negishi</surname><given-names>M</given-names></name>
<etal/>
</person-group>. (<year>1992</year>) <article-title>Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells</article-title>. <source>J Biol Chem</source> <volume>267</volume>: <fpage>2437</fpage>â<lpage>2442</lpage>.</citation>
</ref>
<ref id="bibr76-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakaya</surname><given-names>Y</given-names></name>
<name><surname>Kaneko</surname><given-names>T</given-names></name>
<name><surname>Shigemoto</surname><given-names>R</given-names></name>
<etal/>
</person-group>. (<year>1994</year>) <article-title>Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat</article-title>. <source>J Comp Neurol</source> <volume>347</volume>: <fpage>249</fpage>â<lpage>274</lpage>.</citation>
</ref>
<ref id="bibr77-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nocjar</surname><given-names>C</given-names></name>
<name><surname>Roth</surname><given-names>BL</given-names></name>
<name><surname>Pehek</surname><given-names>EA</given-names></name>
</person-group> (<year>2002</year>) <article-title>Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group</article-title>. <source>Neuroscience</source> <volume>111</volume>: <fpage>163</fpage>â<lpage>176</lpage>.</citation>
</ref>
<ref id="bibr78-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Olver</surname><given-names>JS</given-names></name>
<name><surname>Ignatiadis</surname><given-names>S</given-names></name>
<name><surname>Maruff</surname><given-names>P</given-names></name>
<etal/>
</person-group>. (<year>2008</year>) <article-title>Quetiapine augmentation in depressed patients with partial response to antidepressants</article-title>. <source>Hum Psychopharmacol</source> <volume>23</volume>: <fpage>653</fpage>â<lpage>660</lpage>.</citation>
</ref>
<ref id="bibr79-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ou</surname><given-names>XM</given-names></name>
<name><surname>Lemonde</surname><given-names>S</given-names></name>
<name><surname>Jafar-Nejad</surname><given-names>H</given-names></name>
<etal/>
</person-group>. (<year>2003</year>) <article-title>Freud-1: a neuronal calcium-regulated repressor of the 5-HT1A receptor gene</article-title>. <source>J Neurosci</source> <volume>23</volume>: <fpage>7415</fpage>â<lpage>7425</lpage>.</citation>
</ref>
<ref id="bibr80-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Page</surname><given-names>NM</given-names></name>
</person-group> (<year>2005</year>) <article-title>New challenges in the study of the mammalian tachykinins</article-title>. <source>Peptides</source> <volume>26</volume>: <fpage>1356</fpage>â<lpage>1368</lpage>.</citation>
</ref>
<ref id="bibr81-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Papp</surname><given-names>M</given-names></name>
<name><surname>Vassout</surname><given-names>A</given-names></name>
<name><surname>Gentsch</surname><given-names>C</given-names></name>
</person-group> (<year>2000</year>) <article-title>The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats</article-title>. <source>Behav Brain Res</source> <volume>115</volume>: <fpage>19</fpage>â<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr82-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Patel</surname><given-names>TD</given-names></name>
<name><surname>Azmitia</surname><given-names>EC</given-names></name>
<name><surname>Zhou</surname><given-names>FC</given-names></name>
</person-group> (<year>1996</year>) <article-title>Increased 5-HT1A receptor immunoreactivity in the rat hippocampus following 5,7-dihydroxytryptamine lesions in the cingulum bundle and fimbria-fornix</article-title>. <source>Behav Brain Res</source> <volume>73</volume>: <fpage>319</fpage>â<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr83-0269881111425969">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Paxinos</surname><given-names>G</given-names></name>
<name><surname>Watson</surname><given-names>C</given-names></name>
</person-group> (<year>1998</year>) <source>The Rat Brain in Streretaxic Coordinates</source>. <publisher-loc>New York, USA</publisher-loc>: <publisher-name>Academic Press</publisher-name>.</citation>
</ref>
<ref id="bibr84-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peddie</surname><given-names>CJ</given-names></name>
<name><surname>Davies</surname><given-names>HA</given-names></name>
<name><surname>Colyer</surname><given-names>FM</given-names></name>
<etal/>
</person-group>. (<year>2008</year>) <article-title>Colocalisation of serotonin2A receptors with the glutamate receptor subunits NR1 and GluR2 in the dentate gyrus: an ultrastructural study of a modulatory role</article-title>. <source>Exp Neurol</source> <volume>211</volume>: <fpage>561</fpage>â<lpage>573</lpage>.</citation>
</ref>
<ref id="bibr85-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pennefather</surname><given-names>JN</given-names></name>
<name><surname>Lecci</surname><given-names>A</given-names></name>
<name><surname>Candenas</surname><given-names>ML</given-names></name>
<etal/>
</person-group>. (<year>2004</year>) <article-title>Tachykinins and tachykinin receptors: a growing family</article-title>. <source>Life Sci</source> <volume>74</volume>: <fpage>1445</fpage>â<lpage>1463</lpage>.</citation>
</ref>
<ref id="bibr86-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Piggins</surname><given-names>HD</given-names></name>
<name><surname>Samuels</surname><given-names>RE</given-names></name>
<name><surname>Coogan</surname><given-names>AN</given-names></name>
<etal/>
</person-group>. (<year>2001</year>) <article-title>Distribution of substance P and neurokinin-1 receptor immunoreactivity in the suprachiasmatic nuclei and intergeniculate leaflet of hamster, mouse, and rat</article-title>. <source>J Comp Neurol</source> <volume>438</volume>: <fpage>50</fpage>â<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr87-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pompeiano</surname><given-names>M</given-names></name>
<name><surname>Palacios</surname><given-names>JM</given-names></name>
<name><surname>Mengod</surname><given-names>G</given-names></name>
</person-group> (<year>1992</year>) <article-title>Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding</article-title>. <source>J Neurosci</source> <volume>12</volume>: <fpage>440</fpage>â<lpage>453</lpage>.</citation>
</ref>
<ref id="bibr88-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Riad</surname><given-names>M</given-names></name>
<name><surname>Zimmer</surname><given-names>L</given-names></name>
<name><surname>Rbah</surname><given-names>L</given-names></name>
<etal/>
</person-group>. (<year>2004</year>) <article-title>Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat</article-title>. <source>J Neurosci</source> <volume>24</volume>: <fpage>5420</fpage>â<lpage>5426</lpage>.</citation>
</ref>
<ref id="bibr89-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rotzinger</surname><given-names>S</given-names></name>
<name><surname>Lovejoy</surname><given-names>DA</given-names></name>
<name><surname>Tan</surname><given-names>LA</given-names></name>
</person-group> (<year>2010</year>) <article-title>Behavioral effects of neuropeptides in rodent models of depression and anxiety</article-title>. <source>Peptides</source> <volume>31</volume>: <fpage>736</fpage>â<lpage>756</lpage>.</citation>
</ref>
<ref id="bibr90-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rupniak</surname><given-names>NM</given-names></name>
<name><surname>Kramer</surname><given-names>MS</given-names></name>
</person-group> (<year>1999</year>) <article-title>Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists</article-title>. <source>Trends Pharmacol Sci</source> <volume>20</volume>: <fpage>485</fpage>â<lpage>490</lpage>.</citation>
</ref>
<ref id="bibr91-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rush</surname><given-names>AJ</given-names></name>
<name><surname>Warden</surname><given-names>D</given-names></name>
<name><surname>Wisniewski</surname><given-names>SR</given-names></name>
<etal/>
</person-group>. (<year>2009</year>) <article-title>STAR*D: revising conventional wisdom</article-title>. <source>CNS Drugs</source> <volume>23</volume>: <fpage>627</fpage>â<lpage>647</lpage>.</citation>
</ref>
<ref id="bibr92-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santarelli</surname><given-names>L</given-names></name>
<name><surname>Gobbi</surname><given-names>G</given-names></name>
<name><surname>Debs</surname><given-names>PC</given-names></name>
<etal/>
</person-group>. (<year>2001</year>) <article-title>Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>98</volume>: <fpage>1912</fpage>â<lpage>1917</lpage>.</citation>
</ref>
<ref id="bibr93-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santarelli</surname><given-names>L</given-names></name>
<name><surname>Saxe</surname><given-names>M</given-names></name>
<name><surname>Gross</surname><given-names>C</given-names></name>
<etal/>
</person-group>. (<year>2003</year>) <article-title>Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants</article-title>. <source>Science</source> <volume>301</volume>: <fpage>805</fpage>â<lpage>809</lpage>.</citation>
</ref>
<ref id="bibr94-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sargent</surname><given-names>PA</given-names></name>
<name><surname>Kjaer</surname><given-names>KH</given-names></name>
<name><surname>Bench</surname><given-names>CJ</given-names></name>
<etal/>
</person-group>. (<year>2000</year>) <article-title>Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment</article-title>. <source>Arch Gen Psychiatry</source> <volume>57</volume>: <fpage>174</fpage>â<lpage>180</lpage>.</citation>
</ref>
<ref id="bibr95-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Satake</surname><given-names>H</given-names></name>
<name><surname>Kawada</surname><given-names>T</given-names></name>
</person-group> (<year>2006</year>) <article-title>Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors</article-title>. <source>Curr Drug Targets</source> <volume>7</volume>: <fpage>963</fpage>â<lpage>974</lpage>.</citation>
</ref>
<ref id="bibr96-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schreiber</surname><given-names>R</given-names></name>
<name><surname>De Vry</surname><given-names>J</given-names></name>
</person-group> (<year>1993</year>) <article-title>Neuroanatomical basis for the antidepressant-like effects of the 5-HT(1A) receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test</article-title>. <source>Behav Pharmacol</source> <volume>4</volume>: <fpage>625</fpage>â<lpage>636</lpage>.</citation>
</ref>
<ref id="bibr97-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shigemoto</surname><given-names>R</given-names></name>
<name><surname>Nakaya</surname><given-names>Y</given-names></name>
<name><surname>Nomura</surname><given-names>S</given-names></name>
<etal/>
</person-group>. (<year>1993</year>) <article-title>Immunocytochemical localization of rat substance P receptor in the striatum</article-title>. <source>Neurosci Lett</source> <volume>153</volume>: <fpage>157</fpage>â<lpage>160</lpage>.</citation>
</ref>
<ref id="bibr98-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sloviter</surname><given-names>RS</given-names></name>
<name><surname>Ali-Akbarian</surname><given-names>L</given-names></name>
<name><surname>Horvath</surname><given-names>KD</given-names></name>
<etal/>
</person-group>. (<year>2001</year>) <article-title>Substance P receptor expression by inhibitory interneurons of the rat hippocampus: enhanced detection using improved immunocytochemical methods for the preservation and colocalization of GABA and other neuronal markers</article-title>. <source>J Comp Neurol</source> <volume>430</volume>: <fpage>283</fpage>â<lpage>305</lpage>.</citation>
</ref>
<ref id="bibr99-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stein</surname><given-names>C</given-names></name>
<name><surname>Davidowa</surname><given-names>H</given-names></name>
<name><surname>Albrecht</surname><given-names>D</given-names></name>
</person-group> (<year>2000</year>) <article-title>5-HT(1A) receptor-mediated inhibition and 5-HT(2) as well as 5-HT(3) receptor-mediated excitation in different subdivisions of the rat amygdala</article-title>. <source>Synapse</source> <volume>38</volume>: <fpage>328</fpage>â<lpage>337</lpage>.</citation>
</ref>
<ref id="bibr100-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stockmeier</surname><given-names>CA</given-names></name>
</person-group> (<year>2003</year>) <article-title>Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter</article-title>. <source>J Psychiatr Res</source> <volume>37</volume>: <fpage>357</fpage>â<lpage>373</lpage>.</citation>
</ref>
<ref id="bibr101-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stockmeier</surname><given-names>CA</given-names></name>
<name><surname>Shi</surname><given-names>X</given-names></name>
<name><surname>Konick</surname><given-names>L</given-names></name>
<etal/>
</person-group>. (<year>2002</year>) <article-title>Neurokinin-1 receptors are decreased in major depressive disorder</article-title>. <source>Neuroreport</source> <volume>13</volume>: <fpage>1223</fpage>â<lpage>1227</lpage>.</citation>
</ref>
<ref id="bibr102-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Teixeira</surname><given-names>RM</given-names></name>
<name><surname>Santos</surname><given-names>AR</given-names></name>
<name><surname>Ribeiro</surname><given-names>SJ</given-names></name>
<etal/>
</person-group>. (<year>1996</year>) <article-title>Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice</article-title>. <source>Eur J Pharmacol</source> <volume>311</volume>: <fpage>7</fpage>â<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr103-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Valentino</surname><given-names>RJ</given-names></name>
<name><surname>Bey</surname><given-names>V</given-names></name>
<name><surname>Pernar</surname><given-names>L</given-names></name>
<etal/>
</person-group>. (<year>2003</year>) <article-title>Substance P acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity</article-title>. <source>J Neurosci</source> <volume>23</volume>: <fpage>7155</fpage>â<lpage>7159</lpage>.</citation>
</ref>
<ref id="bibr104-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vigna</surname><given-names>SR</given-names></name>
<name><surname>Bowden</surname><given-names>JJ</given-names></name>
<name><surname>McDonald</surname><given-names>DM</given-names></name>
<etal/>
</person-group>. (<year>1994</year>) <article-title>Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells</article-title>. <source>J Neurosci</source> <volume>14</volume>: <fpage>834</fpage>â<lpage>845</lpage>.</citation>
</ref>
<ref id="bibr105-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>SJ</given-names></name>
<name><surname>Cheng</surname><given-names>LL</given-names></name>
<name><surname>Gean</surname><given-names>PW</given-names></name>
</person-group> (<year>1999</year>) <article-title>Cross-modulation of synaptic plasticity by beta-adrenergic and 5-HT1A receptors in the rat basolateral amygdala</article-title>. <source>J Neurosci</source> <volume>19</volume>: <fpage>570</fpage>â<lpage>577</lpage>.</citation>
</ref>
<ref id="bibr106-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Willins</surname><given-names>DL</given-names></name>
<name><surname>Berry</surname><given-names>SA</given-names></name>
<name><surname>Alsayegh</surname><given-names>L</given-names></name>
<etal/>
</person-group>. (<year>1999</year>) <article-title>Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo</article-title>. <source>Neuroscience</source> <volume>91</volume>: <fpage>599</fpage>â<lpage>606</lpage>.</citation>
</ref>
<ref id="bibr107-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wright</surname><given-names>DE</given-names></name>
<name><surname>Seroogy</surname><given-names>KB</given-names></name>
<name><surname>Lundgren</surname><given-names>KH</given-names></name>
<etal/>
</person-group>. (<year>1995</year>) <article-title>Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain</article-title>. <source>J Comp Neurol</source> <volume>351</volume>: <fpage>357</fpage>â<lpage>373</lpage>.</citation>
</ref>
<ref id="bibr108-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>C</given-names></name>
<name><surname>Yoder</surname><given-names>EJ</given-names></name>
<name><surname>Shih</surname><given-names>J</given-names></name>
<etal/>
</person-group>. (<year>1998</year>) <article-title>Development and characterization of monoclonal antibodies specific to the serotonin 5-HT2A receptor</article-title>. <source>J Histochem Cytochem</source> <volume>46</volume>: <fpage>811</fpage>â<lpage>824</lpage>.</citation>
</ref>
<ref id="bibr109-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname><given-names>T</given-names></name>
<name><surname>Pandey</surname><given-names>SC</given-names></name>
</person-group> (<year>2000</year>) <article-title>Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain</article-title>. <source>Brain Res Bull</source> <volume>51</volume>: <fpage>499</fpage>â<lpage>505</lpage>.</citation>
</ref>
<ref id="bibr110-0269881111425969">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zangrossi</surname><given-names>H</given-names><suffix>Jr</suffix></name>
<name><surname>Viana</surname><given-names>MB</given-names></name>
<name><surname>Graeff</surname><given-names>FG</given-names></name>
</person-group> (<year>1999</year>) <article-title>Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze</article-title>. <source>Eur J Pharmacol</source> <volume>369</volume>: <fpage>267</fpage>â<lpage>270</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>